# EDGAR Filing Document

**Accession Number:** 0001634452
**File Stem:** 0001193125-26-080188
**Filing Date:** 2026-2
**Character Count:** 255962
**Document Hash:** a811b2a9844161adae5c32fb93619379
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-080188.hdr.sgml**: 20260227

**ACCESSION NUMBER**: 0001193125-26-080188

**CONFORMED SUBMISSION TYPE**: SC TO-I

**PUBLIC DOCUMENT COUNT**: 27

**FILED AS OF DATE**: 20260227

**DATE AS OF CHANGE**: 20260227

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AB Private Credit Investors Corp
- **CENTRAL INDEX KEY:** 0001634452

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-90731
- **FILM NUMBER:** 26694465

**BUSINESS ADDRESS:**
- **STREET 1:** 405 COLORADO STREET
- **STREET 2:** SUITE 1500
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701
- **BUSINESS PHONE:** (512) 721-2900

**MAIL ADDRESS:**
- **STREET 1:** 405 COLORADO STREET
- **STREET 2:** SUITE 1500
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AB Private Credit Corp
- **DATE OF NAME CHANGE:** 20150219
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AB Private Credit Investors Corp
- **CENTRAL INDEX KEY:** 0001634452

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** NY
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC TO-I

**BUSINESS ADDRESS:**
- **STREET 1:** 405 COLORADO STREET
- **STREET 2:** SUITE 1500
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701
- **BUSINESS PHONE:** (512) 721-2900

**MAIL ADDRESS:**
- **STREET 1:** 405 COLORADO STREET
- **STREET 2:** SUITE 1500
- **CITY:** AUSTIN
- **STATE:** TX
- **ZIP:** 78701

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** AB Private Credit Corp
- **DATE OF NAME CHANGE:** 20150219

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**SCHEDULE TO** 

**TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934** 

## AB PRIVATE CREDIT INVESTORS CORPORATION
**(Name of Subject Fund (Issuer))** 

**AB PRIVATE CREDIT INVESTORS CORPORATION** 

**(Names of filing Person (Offeror and Issuer))** 

**Common Stock, Par Value $0.01 per share** 

**(Title of Class of Securities)** 

**N/A** 

**(CUSIP Number of Class of Securities)** 

**J. Brent Humphries** 

**Chairman and Chief Executive Officer** 

**AB Private Credit Investors Corporation** 

**405 Colorado Street, Suite 1500** 

**Austin, TX 78701** 

**Tel: (512) 721-2900** 

**(Name, address and telephone number of person authorized to receive notices and communications on behalf of filing person)** 

***Copy to:***

**Kenneth E. Young, Esq.** 

**Paul Stevens, Esq.** 

**Dechert LLP** 

**Cira Centre** 

**2929 Arch Street** 

**Philadelphia, PA 19104** 

**Telephone: (215) 994-4000** 

☐ Check the box if filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

☐ Third-party tender offer subject to Rule 14d-1.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☒ Issuer tender offer subject to Rule 13e-4.

☐ Going-private transaction subject to Rule 13e-3.

☐ Amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer: ☐

------

This Tender Offer Statement on Schedule TO (this "***Schedule TO***") relates to the offer by AB Private Credit Investors Corporation, an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended ("***AB PCIC***" or the "***Fund***"), to purchase for cash up to 1,861,300.28 shares of its common stock, par value $0.01 per share (the "***Shares***"), which represents 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025, which is 74,452,011, at a price per Share equal to its net asset value per Share as of March 31, 2026, on the terms and conditions set out in the Offer to Purchase, dated February 27, 2026 (the "***Offer to Purchase***"), a copy of which is filed herewith as Exhibit (a)(1)(A), and the related Notice of Intent to Tender (the "***Notice of Intent***," and together with the Offer to Purchase, as each may be amended or supplemented from time to time, the "***Offer***"), a copy of which is filed herewith as Exhibit (a)(1)(B). This Schedule TO is intended to satisfy the reporting requirements of Rule 13e-4(c)(2) promulgated under the Securities Exchange Act of 1934, as amended (the "***Exchange Act***").

The information contained in the Offer to Purchase and the Notice of Intent, respectively, as each may be amended or supplemented from time to time, is hereby incorporated by reference in response to certain items of this Schedule TO.

---

| | |
|:---|:---|
| **ITEM 1.** | **SUMMARY TERM SHEET.**  |

---

The information under the heading "Summary Term Sheet" included in the Offer to Purchase is incorporated herein by reference.

---

| | |
|:---|:---|
| **ITEM 2.** | **SUBJECT COMPANY INFORMATION.**  |

---

(a) **Name and Address**. The name of the issuer is AB Private Credit Investors Corporation. The address and
telephone number of the issuer's principal executive offices are: 405 Colorado Street, Suite 1500, Austin, TX 78701 and (512) 721-2900.

(b) **Securities**. The subject securities are AB PCIC's shares of common stock, par value $0.01 per
share. As of February 27, 2026, there were 77,076,221 Shares issued and outstanding.

(c) **Trading Market and Price**. The Shares are not currently traded on an established trading market.

---

| | |
|:---|:---|
| **ITEM 3.** | **IDENTITY AND BACKGROUND OF FILING PERSON.**  |

---

(a) **Name and Address**. The filing person and subject company to which this Schedule TO relates is AB Private
Credit Investors Corporation. The address and telephone number of AB PCIC is set forth under Item 2(a) above. The names of the directors and executive officers of AB PCIC are as set forth in the Offer to Purchase under the heading
"Section 10—Interests of Directors, Executive Officers and Affiliates; Transactions and Arrangements Concerning the Shares," and such information is incorporated herein by reference. The business address and business telephone
number of each director and executive officer of AB PCIC are: c/o AB Private Credit Investors Corporation, 405 Colorado Street, Suite 1500, Austin, TX 78701 and (512) 721-2900.

---

| | |
|:---|:---|
| **ITEM 4.** | **TERMS OF THE TRANSACTION.**  |

---

(a) **Material Terms**. The material terms of the transaction are incorporated herein by reference from the
Offer to Purchase under the headings "Summary Term Sheet," "Introduction," "Section 1—Number of Shares; Purchase Price; Cutbacks," "Section 2—Purpose of the Offer; Certain Effects of
the Offer; Plans or Proposals," "Section 3—Procedures for Tendering Shares," "Section 4—Withdrawal Rights," "Section 5—Purchase of Shares and Payment of Purchase Price,"
"Section 6—Conditions of the Offer," "Section 8—Source and Amount of Funds," "Section 10—Interests of Directors, Executive Officers and Affiliates; Transactions and Arrangements
Concerning the Shares," "Section 13—Material U.S. Federal Income Tax Consequences," and "Section 14—Extension of the Offer; Termination; Amendment." There will be no material differences in the
rights of the remaining security holders of the Fund as a result of this transaction.

(b) **Purchases**. None of our directors, executive officers or, to our knowledge, any of our affiliates intend
to tender any Shares in the Offer. Therefore, the Offer will increase the proportional holdings of our affiliates.

See "Section 2—Purpose of the Offer; Certain Effects of the Offer; Plans or Proposals" of the Offer to Purchase.

---

| | |
|:---|:---|
| **ITEM 5.** | **PAST CONTACTS, TRANSACTIONS, NEGOTIATIONS AND AGREEMENTS.**  |

---

(a) **Agreements Involving the Subject Fund's Securities**. Information regarding agreements involving AB
PCIC's securities is incorporated herein by reference from the Offer to Purchase under the heading "Section 10—Interests of Directors, Executive Officers and Affiliates; Transactions and Arrangements Concerning the
Shares." Except as set forth therein, the Fund does not know of any agreement, arrangement or understanding, whether or not legally enforceable, between the Fund and any other person with respect to the Fund's securities.

------

---

| | |
|:---|:---|
| **ITEM 6.** | **PURPOSES OF THE TRANSACTION AND PLANS OR PROPOSALS.**  |

---

(a) **Purposes**. Information regarding the purpose of the transaction is incorporated herein by reference from
the Offer to Purchase under the heading "Section 2—Purpose of the Offer; Certain Effects of the Offer; Plans or Proposals."

(b) **Use of Securities Acquired**. Information regarding the treatment of Shares acquired pursuant to the Offer
is incorporated herein by reference from the Offer to Purchase under the heading "Section 2—Purpose of the Offer; Certain Effects of the Offer; Plans or Proposals."

(c) **Plans**. Information regarding any plans or proposals is incorporated herein by reference from the Offer
to Purchase under the headings "Section 2—Purpose of the Offer; Certain Effects of the Offer; Plans or Proposals," "Section 7—Price Range of Shares; Distributions," and
"Section 10—Interests of Directors, Executive Officers and Affiliates; Transactions and Arrangements Concerning the Shares."

---

| | |
|:---|:---|
| **ITEM 7.** | **SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.**  |

---

(a) **Source of Funds**. Information regarding the source of funds is incorporated herein by reference from the
Offer to Purchase under the heading "Section 8—Source and Amount of Funds."

---

| | |
|:---|:---|
| **ITEM 8.** | **INTEREST IN SECURITIES OF THE SUBJECT COMPANY.**  |

---

(a) **Securities Ownership**. The information under the heading "Section 10—Interests of
Directors, Executive Officers and Affiliates; Transactions and Arrangements Concerning the Shares" in the Offer to Purchase is incorporated herein by reference.

(b) **Securities Transactions**. The information under the heading "Section 10—Interests of
Directors, Executive Officers and Affiliates; Transactions and Arrangements Concerning the Shares" in the Offer to Purchase is incorporated herein by reference.

---

| | |
|:---|:---|
| **ITEM 9.** | **PERSONS/ASSETS, RETAINED, EMPLOYED, COMPENSATED OR USED.**  |

---

(a) **Solicitations or Recommendations**. The information under the headings "Summary Term Sheet"
and "Section 15—Fees and Expenses" in the Offer to Purchase is incorporated herein by reference.

---

| | |
|:---|:---|
| **ITEM 10.** | **FINANCIAL STATEMENTS.**  |

---

(a) **Financial Information**. (1) Reference is made to the audited financial statements of the Fund for
the fiscal years ended December 31, 2024 and December 31, 2023, respectively, which were prepared by the Fund and were filed with the Securities and Exchange Commission ("  ***SEC***") on March 31, 2025 and
March 29, 2024, respectively. Such financial statements are incorporated herein by reference in their entirety.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Reference is made to the unaudited balance sheets, comparative year-to-date statements of comprehensive income and related earnings per share data and statements of cash flows included in the Fund's quarterly report on Form 10-Q for the fiscal quarter ended September 30, 2025, which was prepared by the Fund and filed with the SEC on November 12, 2025. Such financial statements are incorporated herein by reference in their entirety.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Not applicable.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Net asset value per Share of $9.48 on December 31, 2025.

(b) **Pro Forma Financial Information**. The Fund's assets will be reduced by the amount of the tendered
Shares that are purchased by the Fund. Thus, income relative to assets may be affected by the Offer.

---

| | |
|:---|:---|
| **ITEM 11.** | **ADDITIONAL INFORMATION.**  |

---

(a) **Agreements, Regulatory Requirements and Legal Proceedings**.

(1) The information under the heading "Section 10—Interests of Directors, Executive Officers and
Affiliates; Transactions and Arrangements Concerning the Shares" in the Offer to Purchase is incorporated herein by reference. The Fund will amend this Schedule TO to reflect material changes to information incorporated by reference in the
Offer to Purchase to the extent required by Rule 13e-4(d)(2) promulgated under the Exchange Act.

(2) The information under the heading "Section 12—Certain Legal Matters; Regulatory
Approvals" in the Offer to Purchase is incorporated herein by reference.

(3) Not applicable.

(4) Not applicable.

------

(5) None.

(b) **Other Material Information**. The information set forth in the Offer to Purchase and the Notice of Intent,
copies of which are filed herewith as Exhibits (a)(1)(A) and (a)(1)(B), respectively, as each may be amended or supplemented from time to time, is incorporated herein by reference. The Fund will amend this Schedule TO to include documents that the
Fund may file with the Securities and Exchange Commission after the date of the Offer to Purchase pursuant to Sections 13(a), 13(c), or 14 of the Exchange Act and prior to the expiration of the Offer to the extent required by Rule 13e-4(d)(2) promulgated under the Exchange Act.

---

| | |
|:---|:---|
| **ITEM 12.** | **EXHIBITS.**  |

---

---

| | |
|:---|:---|
| (a)(1)(A) | [Offer to Purchase, dated February 27, 2026.](d111092dex99a1a.htm) |
| (a)(1)(B) | [Notice of Intent to Tender.](d111092dex99a1b.htm) |
| (a)(1)(C) | [Notice of Withdrawal of Tender.](d111092dex99a1c.htm) |
| (a)(1)(D) | [Form of Promissory Note.](d111092dex99a1d.htm) |
| (a)(5)(A) | [Form of Notice to be Published in Barron's.](d111092dex99a5a.htm) |
| (a)(5)(B) | [Form of Letter to Stockholders who are clients of Bernstein in connection with the Fund's acceptance of tenders of Shares.](d111092dex99a5b.htm) |
| (a)(5)(C) | [Form of Letter to Stockholders who are clients of Bernstein in connection with the Fund's calculation of net asset value as of March 31, 2026.](d111092dex99a5c.htm) |

---

------

---

| | |
|:---|:---|
| (b)(1) | Revolving Credit Agreement, dated as of June 14, 2019, by and among AB-Abbott Private Equity Investors 2019 (Delaware) Fund L.P. ("AB PEI 2019"), as initial borrower, AB-Abbott Private Equity Investors G.P. L.P. ("AB PEI") as initial general partner, the banks and financial institutions from time to time party thereto as lenders and HSBC Bank USA, National Association ("HSBC") as the administrative agent for the secured parties (as amended, restated, supplemented or otherwise modified from time to time) (incorporated by reference to [Exhibit 10.2](http://www.sec.gov/Archives/edgar/data/1634452/000119312521215304/d165208dex102.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on July 14, 2021), as amended by that certain Sixth Amendment to Revolving Credit Agreement, dated as of June 10, 2022, by and among AB PEI 2019, AB-Abbott Private Equity Investors 2020 (Delaware) Fund L.P. ("AB PEI 2020"), AB-Abbott Private Equity Solutions 2021 (Delaware) Fund L.P. ("AB PEI 2021"), AB Private Credit Investors Middle Market Direct Lending Fund, L.P. ("AB MMDLF"), the Fund and AB-Abbott Private Equity Solutions 2022 (Delaware) Fund L.P. ("AB PES 2022"), as borrowers, AB PEI, AB-Abbott Private Equity Investors 2020 G.P. L.P. ("AB PEI 2020 GP LP"), AB-Abbott Private Equity Solutions 2021 G.P. L.P. ("AB PES 2021 GP LP"), AB Private Credit Investors Middle Market Direct Lending G.P. L.P. ("AB MMDLF GP LP") and AB-Abbott Private Equity Solutions 2022 G.P. L.P. ("AB PES 2022 GP LP"), as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312522173891/d368784dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on June 14, 2022), as further amended by that certain Seventh Amendment to Revolving Credit Agreement, dated as of November 10, 2022, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund and AB PES 2022, as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP and AB PES 2022 GP LP, as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312522286445/d410819dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on November 16, 2022), as further amended by that certain Ninth Amendment to Revolving Credit Agreement, dated as of June 9, 2023, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022 and AB-Abbott Private Equity Solutions 2023 (Delaware) Fund L.P. ("AB PES 2023"), as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP, AB PES 2022 GP LP and AB-Abbott Private Equity Solutions 2023 G.P. L.P. ("AB PES 2023 GP LP"), as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312523165832/d445485dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on June 13, 2023), as further amended by that certain Tenth Amendment to Revolving Credit Agreement, dated as of November 15, 2023, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022 and AB PES 2023, as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP, AB PES 2022 GP LP and AB PES 2023 GP LP, as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312523279384/d549740dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on November 17, 2023), as further amended by that certain Twelfth Amendment to Revolving Credit Agreement, dated as of June 6, 2024, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022, AB PES 2023 and AB-Abbott Private Equity Solutions 2024 (Delaware) Fund L.P. ("AB PES 2024"), as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP, AB PES 2022 GP LP, AB PES 2023 GP LP and AB-Abbott Private Equity Solutions 2024 G.P. L.P. ("AB PES 2024 GP LP"), as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312524157953/d628583dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on June 10, 2024), as further amended by that certain Lender Joinder and Thirteenth Amendment to Revolving Credit Agreement, dated as of August 30, 2024, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022, AB PES 2023 and AB PES 2024, as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP, AB PES 2022 GP LP, AB PES 2023 GP LP and AB PES 2024 GP LP, as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312524214783/d831649dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on September 6, 2024), as further amended by that certain Fourteenth Amendment to Revolving Credit Agreement, dated as of November 15, 2024, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022, AB PES 2023 and AB PES 2024, as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP, AB PES 2022 GP LP, AB PES 2023 GP LP and AB PES 2024 GP LP, as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312524261712/d895858dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on November 19, 2024), as further amended by that certain Fifteenth Amendment to Revolving Credit Agreement, dated as of February 14, 2025, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022, AB PES 2023 and AB PES 2024, as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP, AB PES 2022 GP LP, AB PES 2023 GP LP and AB PES 2024 GP LP, as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312525028137/d908621dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on February 18, 2025), as further amended by that certain Sixteenth Amendment to Revolving Credit Agreement, dated as of May 6, 2025, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022, AB PES 2023, AB PES 2024 and AB-Abbott Private Equity Solutions 2025 (Delaware) Fund L.P. ("AB PES 2025"), as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP, AB PES 2022 GP LP, AB PES 2023 GP LP, AB PES 2024 GP LP and AB-Abbott Private Equity Solutions 2025 G.P. L.P. ("AB PES 2025 GP LP"), as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312525119565/d891842dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on May 14, 2025), as further amended by that certain Fund Group Facility Sublimit Adjustment Letter, dated as of October 24, 2025, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022, AB PES 2023 and AB PES 2024, and as further amended by that certain Borrower Joinder, Lender Joinder and Seventeenth Amendment to Revolving Credit Agreement, dated as of December 8, 2025, by and among AB PEI 2019, AB PEI 2020, AB PEI 2021, AB MMDLF, the Fund, AB PES 2022, AB PES 2023, AB PES 2024, AB PES 2025 and AB Private Credit Investors Middle Market Direct Lending Fund II, L.P ("AB PCI MMDL II"), as borrowers, AB PEI, AB PEI 2020 GP LP, AB PES 2021 GP LP, AB MMDLF GP LP, AB PES 2022 GP LP, AB PES 2023 GP LP, AB PES 2024 GP LP, AB PES 2025 GP LP and AB Private Credit Investors Middle Market Direct Lending G.P. L.P ("AB PCI MMDL GP LP"), as general partners, the banks and financial institutions from time to time party thereto as lenders and HSBC as the administrative agent for the secured parties and a lender (incorporated by reference to [Exhibit 10.1](http://www.sec.gov/Archives/edgar/data/1634452/000119312525317312/d592989dex101.htm) to the Fund's Current Report on Form 8-K (File No. 814-01196) filed on December 12, 2025). |
| 107 | [Calculation of Filing Fees Table.](d111092dexfilingfees.htm) |

---

------

---

| | |
|:---|:---|
| **ITEM 13.** | **INFORMATION REQUIRED BY SCHEDULE 13E-3.**  |

---

Not applicable.

------

**SIGNATURE** 

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 27, 2026

---

| | |
|:---|:---|
| AB PRIVATE CREDIT INVESTORS CORPORATION | AB PRIVATE CREDIT INVESTORS CORPORATION |
| By: | /s/ Leon Hirth |
| Name: | Leon Hirth |
| Title: | Secretary |

---

## Ex-99.(A)(1)(A)

**Exhibit (a)(1)(A)** 

**AB Private Credit Investors Corporation** 

**Offer to Purchase for Cash** 

**Up to 1,861,300.28 Shares of its Common Stock** 

**at a Purchase Price Per Share of Common Stock Equal to** 

**its Net Asset Value per Share as of March 31, 2026** 

**THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON** 

**March 31, 2026, UNLESS THE OFFER IS EXTENDED OR WITHDRAWN (SUCH TIME AND DATE, AS THEY MAY BE EXTENDED, THE "*EXPIRATION DATE*").** 

AB Private Credit Investors Corporation, an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "***Fund***," "***AB PCIC***," "***we***" or "***us***"), is offering to purchase for cash on the terms and conditions set out in this Offer to Purchase, dated February 27, 2026 (the "***Offer to Purchase***"), and the related Notice of Intent to Tender (the "***Notice of Intent***," and together with the Offer to Purchase, as each may be amended or supplemented from time to time, the "***Offer***") up to 1,861,300.28 of its shares of common stock, par value $0.01 per share (the "***Shares***"), at a price per Share equal to its net asset value per Share as of March 31, 2026.

The unaudited net asset value per Share as of December 31, 2025 was $9.48. The Fund cannot give any assurance that net asset value per Share as of March 31, 2026 will not differ (perhaps significantly) from the net asset value per Share as of December 31, 2025.

**The Offer will expire at 5:00 p.m., New York City time, on the Expiration Date. To tender your Shares you must follow the procedures described in the Offer to Purchase, the Notice of Intent and the other documents related to the Offer.** 

The Fund is offering to purchase up to 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025, which is 1,861,300.28 (the "***Quarterly Tender Cap***"). The Fund is not required to purchase any tendered Shares in excess of the Quarterly Tender Cap. This Offer is being made to all stockholders of the Fund and is not conditioned on any minimum amount of Shares being tendered, but is subject to certain conditions described below. Shares are not traded on any established trading market and are subject to strict restrictions on transferability pursuant to the stockholders' subscription agreements with the Fund. For further information on the Quarterly Tender Cap, see Sections 1 and 2.

The Fund is continuously offering Shares pursuant to commitments from stockholders ("***Capital Commitments***"). While all stockholders of the Fund may participate in this Offer, stockholders who entered into a Capital Commitment on or before February 27, 2023 that elect to tender Shares in the Offer by delivering a Notice of Intent will be electing a liquidity option and therefore that Capital Commitment will be released, except with respect to certain specified post-commitment obligations. Participation in the Offer by a stockholder that entered into a Capital Commitment after February 27, 2023 will have no effect on that Capital Commitment.

We will not accept Shares subject to conditional tenders, such as acceptance of all or none of the Shares tendered by any tendering stockholder. If any tendered Shares are not purchased for any reason, the Notice of Intent with respect to such Shares not purchased will be of no force or effect. Shares tendered but not purchased pursuant to the Offer will be returned promptly following the Expiration Date. See Sections 3 and 4.

Subject to the applicable rules and regulations promulgated by the Securities and Exchange Commission (the "***SEC***"), we expressly reserve the right, in our sole discretion, at any time and from time to time, (a) to extend the period of time during which the Offer is open and thereby delay acceptance for payment of, and the payment for, any Shares, subject to the restrictions below, (b) to increase or decrease the value of Shares sought in the Offer, (c) to amend the Offer in any respect prior to the Expiration Date and (d) if any condition specified in Section 6 is not satisfied or waived prior to the Expiration Date, to terminate the Offer and not accept any Shares for payment. Notice of any such extension, amendment or termination will be distributed promptly to stockholders in a manner reasonably designed to inform them of such change in compliance with Rule 13e-4(e)(3) promulgated under the Securities Exchange Act of 1934, as amended (the "***Exchange Act***"). In the case of an extension of the Offer, such extension will be followed by a press release or other public announcement, which will be issued no later than 9:00 a.m., New York City time, on the next business day after the scheduled Expiration Date, in accordance with Rule 14e-1(d) promulgated under the Exchange Act. See Sections 1, 3, 4 and 14.

**The Offer is not conditioned upon the receipt of financing or any minimum number of Shares being tendered. The Offer is, however, subject to a number of other terms and conditions. See Section 6.** 

We expect to use available cash and/or may use borrowings under the Fund's revolving credit facility to fund any purchases of Shares in the Offer and to pay all related fees and expenses. See Section 8.

ALTHOUGH OUR BOARD OF DIRECTORS HAS AUTHORIZED THE OFFER, NONE OF THE FUND, ANY MEMBER OF OUR BOARD OF DIRECTORS OR AB PCI (EACH AS DEFINED HEREIN) OR ANY OF THEIR RESPECTIVE AFFILIATES HAS MADE, OR IS MAKING, ANY RECOMMENDATION TO YOU AS TO WHETHER TO TENDER OR REFRAIN FROM TENDERING YOUR SHARES. YOU MUST MAKE YOUR OWN DECISION AS TO WHETHER TO TENDER YOUR SHARES AND HOW MANY SHARES TO TENDER. IN DOING SO, YOU SHOULD READ CAREFULLY THE INFORMATION IN OR INCORPORATED BY REFERENCE IN THIS OFFER TO PURCHASE AND THE NOTICE OF INTENT, INCLUDING THE PURPOSES AND EFFECTS OF THE OFFER. SEE SECTION 2. YOU ARE URGED TO DISCUSS YOUR DECISION WITH YOUR FINANCIAL ADVISOR AND/OR TAX ADVISOR.

------

IF YOUR TENDERED SHARES ARE ACCEPTED AND YOU ARE A U.S. HOLDER (AS DEFINED IN SECTION 13), THE SALE OF YOUR TENDERED SHARES PURSUANT TO THE OFFER WILL BE A TAXABLE TRANSACTION FOR U.S. FEDERAL INCOME TAX PURPOSES AND GENERALLY WILL BE TREATED FOR U.S. FEDERAL INCOME TAX PURPOSES EITHER AS A (A) SALE OR EXCHANGE ELIGIBLE FOR CAPITAL GAIN OR LOSS TREATMENT, OR (B) DISTRIBUTION TAXABLE AS ORDINARY INCOME TO THE EXTENT IT IS OUT OF OUR CURRENT OR ACCUMULATED EARNINGS AND PROFITS (AND NOT DESIGNATED BY US AS A CAPITAL GAIN DIVIDEND OR QUALIFIED DIVIDEND INCOME). IF YOU ARE A NON-U.S. HOLDER (AS DEFINED IN SECTION 13), WE WILL WITHHOLD ON THE CASH PAYMENT IN RESPECT OF THE PROMISSORY NOTE RECEIVED FOR YOUR TENDERED SHARES. SEE SECTION 13. WE URGE YOU TO CONSULT YOUR TAX ADVISORS AS TO THE PARTICULAR TAX CONSEQUENCES TO YOU TENDERING YOUR SHARES.

**NONE OF THE SEC, ANY STATE SECURITIES COMMISSION NOR ANY OTHER REGULATORY BODY HAS APPROVED OR DISAPPROVED OF THIS TRANSACTION, PASSED UPON THE MERITS OR FAIRNESS OF THIS TRANSACTION OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE INFORMATION INCLUDED OR INCORPORATED BY REFERENCE IN THIS OFFER TO PURCHASE AND ANY RELATED DOCUMENTS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.** 

Questions and requests for assistance by stockholders may be directed to the Fund, at the address listed below, or to your financial advisor.

AB Private Credit Investors Corporation

66 Hudson Boulevard East

New York, NY 10001

Phone: (212) 969-1000

**PLEASE DISCUSS THIS OFFER TO PURCHASE WITH YOUR FINANCIAL ADVISOR PRIOR TO MAKING AN INVESTMENT DECISION.** 

**Offer to Purchase dated February 27, 2026** 

**IMPORTANT** 

WE HAVE NOT AUTHORIZED ANY PERSON TO MAKE ANY RECOMMENDATION ON OUR BEHALF AS TO WHETHER YOU SHOULD TENDER OR REFRAIN FROM TENDERING YOUR SHARES IN THE OFFER. YOU SHOULD RELY ONLY ON THE INFORMATION IN, OR INCORPORATED BY REFERENCE IN, THIS OFFER TO PURCHASE AND THE NOTICE OF INTENT OR IN THE OTHER DOCUMENTS TO WHICH WE HAVE REFERRED YOU. OUR DELIVERY OF THIS OFFER TO PURCHASE SHALL NOT UNDER ANY CIRCUMSTANCES CREATE ANY IMPLICATION THAT THE INFORMATION IN THIS OFFER TO PURCHASE IS CORRECT AS OF ANY TIME OTHER THAN THE DATE OF THIS OFFER TO PURCHASE OR THAT THERE HAVE BEEN NO CHANGES IN THE INFORMATION IN OR INCORPORATED BY REFERENCE HEREIN OR IN THE AFFAIRS OF AB PCIC OR ANY OF ITS SUBSIDIARIES SINCE THE DATE HEREOF. WE HAVE NOT AUTHORIZED ANYONE TO PROVIDE YOU WITH INFORMATION IN CONNECTION WITH THE OFFER OTHER THAN THE INFORMATION IN THIS OFFER TO PURCHASE OR THE NOTICE OF INTENT. IF ANYONE MAKES ANY RECOMMENDATION OR GIVES ANY INFORMATION, YOU MUST NOT RELY UPON THAT RECOMMENDATION OR INFORMATION AS HAVING BEEN AUTHORIZED BY US, ANY MEMBER OF OUR BOARD OF DIRECTORS, AB PRIVATE CREDIT INVESTORS LLC, THE FUND'S INVESTMENT ADVISER ("***AB PCI***") OR ANY OF OUR OR THEIR RESPECTIVE AFFILIATES.

THIS OFFER TO PURCHASE AND THE NOTICE OF INTENT CONTAIN IMPORTANT INFORMATION, AND YOU SHOULD CAREFULLY READ BOTH IN THEIR ENTIRETY BEFORE MAKING A DECISION WITH RESPECT TO THE OFFER.

If you want to tender any portion of your Shares, you must complete and sign the Notice of Intent (or an originally signed photocopy of the Notice of Intent) according to its instructions and deliver it (by email, facsimile, regular mail, overnight courier or hand delivery), together with any other documents required by the Notice of Intent, to your Bernstein financial advisor prior to 5:00 p.m. New York City time on the Expiration Date. If you do not have a Bernstein financial advisor, the Notice of Intent should be sent to the Fund's transfer agent, AllianceBernstein Investor Services, Inc. ("***ABIS***"), at the address shown on the Notice of Intent.

Stockholders properly tendering Shares can reasonably expect to have at least a portion of such Shares purchased if any Shares are purchased pursuant to the Offer (subject to the provisions relating to cutbacks).

We are not aware of any jurisdiction where the making of the Offer is prohibited by any administrative or judicial action pursuant to any valid state statute. If we become aware of any valid state statute prohibiting the making of the Offer or the acceptance of the Shares, we will make a good faith effort to comply with that state statute or seek to have such statute declared inapplicable to the Offer. If, after a good faith effort, we cannot comply with the state statute, we will not make the Offer to, nor will we accept tenders from or on behalf of, the holders of Shares in that state. In any jurisdiction where the securities, blue sky or other laws require the Offer to be made by a licensed broker or dealer, the Offer shall be deemed to be made by one or more registered brokers or dealers licensed under the laws of that jurisdiction.

------

**TABLE OF CONTENTS** 

---

| | | |
|:---|:---|:---|
| | | **Page** |
|  SUMMARY TERM SHEET | SUMMARY TERM SHEET | 2 |
|  FORWARD-LOOKING STATEMENTS | FORWARD-LOOKING STATEMENTS | 7 |
|  INTRODUCTION | INTRODUCTION | 8 |
|  THE OFFER | THE OFFER | 9 |
| 1. | Number of Shares; Purchase Price; Cutbacks | 9 |
| 2. | Purpose of the Offer; Certain Effects of the Offer; Plans or Proposals | 11 |
| 3. | Procedures for Tendering Shares | 12 |
| 4. | Withdrawal Rights | 14 |
| 5. | Purchase of Shares and Payment of Purchase Price | 14 |
| 6. | Conditions of the Offer | 15 |
| 7. | Distributions | 17 |
| 8. | Source and Amount of Funds | 18 |
| 9. | Certain Information Concerning the Fund | 18 |
| 10. | Interests of Directors, Executive Officers and Affiliates; Transactions and Arrangements Concerning the Shares | 20 |
| 11. | Registration under the Exchange Act | 21 |
| 12. | Certain Legal Matters; Regulatory Approvals | 21 |
| 13. | Material U.S. Federal Income Tax Consequences | 21 |
| 14. | Extension of the Offer; Termination; Amendment | 24 |
| 15. | Fees and Expenses | 25 |
| 16. | Miscellaneous | 25 |

---

------

**SUMMARY TERM SHEET** 

We are providing this summary term sheet for your convenience. This summary term sheet highlights certain material information in this Offer to Purchase (as defined below), but you should realize that it does not describe all of the details of the Offer (as defined below) to the same extent described elsewhere in this Offer to Purchase. To understand the Offer fully and for a more complete description of the terms and conditions of the Offer, you should read carefully this entire Offer to Purchase, the Notice of Intent (as defined below) and the other documents related to the Offer. We have included in this summary term sheet references to the sections of this Offer to Purchase where you will find a more complete description of the topics in this summary term sheet.

**Who is offering to purchase my Shares?** 

AB Private Credit Investors Corporation, which we refer to as the "***Fund***," "***AB PCIC***," "***we***" or "***us***."

**What will be the purchase price for the Shares and what will be the form of payment?** 

We are offering to purchase for cash up to 1,861,300.28 of our shares of common stock, par value $0.01 per share (the "***Shares***"), pursuant to tenders at a price per Share equal to our net asset value per Share as of March 31, 2026 (the "***Purchase Price***," and such date, as it may be extended, the "***Expiration Date***"), upon the terms and subject to the conditions described in this Offer to Purchase, dated February 27, 2026 (this "***Offer to Purchase***") and the related Notice of Intent to Tender (the "***Notice of Intent***," which together with the Offer to Purchase, as they may be amended or supplemented from time to time, constitute the "***Offer***").

If you tender Shares and we purchase those Shares, we will issue you a non-interest bearing, non-transferrable promissory note (a "***Note***") entitling you to an amount in cash equal to the number of your Shares accepted for purchase multiplied by the Purchase Price, deliverable promptly after the Expiration Date. The Note will be held for you in an account with ABIS, the Fund's transfer agent and agent designated for this purpose. If you wish to receive a copy of your Note, you may contact your Bernstein financial advisor or the Fund at (212) 969-1000, Monday through Friday, except holidays, during normal business hours of 9:00 a.m. to 5:00 p.m., New York time, to request that a copy be sent to you by mail.

We will not accept Shares subject to conditional tenders, such as acceptance of all or none of the Shares tendered by any tendering stockholder.

**How many Shares is AB PCIC offering to purchase?** 

We are offering to purchase, at the Purchase Price, up to 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025 (the "***Quarterly Tender Cap***"). The Fund is not required to purchase any tendered Shares in excess of the Quarterly Tender Cap and, therefore, the Fund is not required to purchase, and will not purchase, any tendered Shares to the extent those Shares are, in the aggregate, in excess of 1,861,300.28.

The Offer is not conditioned upon the receipt of financing or any minimum number of Shares being tendered. The Offer is, however, subject to a number of other terms and conditions. See Section 6.

**How was the Purchase Price under the Offer determined?** 

We determined the Purchase Price under the Offer based on consultations among our management, our professional advisors and our Board of Directors. Based on such consultations, we concluded that the Purchase Price, which will be the Fund's net asset value per Share as of March 31, 2026 as determined by our Board of Directors, will be representative of the per share value of the Shares and within the range at which (a) our stockholders might sell their Shares to us and (b) we can prudently effect purchases for the benefit of the Fund. The actual value of our Shares may be lower or higher than the Purchase Price.

**How will AB PCIC pay for the Shares?** 

For each stockholder who tenders Shares that are accepted for purchase, payment of the Purchase Price will consist of a Note entitling the stockholder to receive a cash payment in an amount per Share equal to the net asset value of such Shares, determined as of March 31, 2026. Payment of this amount will be made to you approximately 45 days after the Expiration Date.

We will pay for your properly tendered and not properly withdrawn Shares by delivering a Note. In all cases, delivery of a Note for properly tendered Shares will be made only after timely receipt by your financial advisor of a properly completed and duly executed Notice of Intent, and other documents required by the Notice of Intent. See Sections 3 and 5.

The Note, pursuant to which a tendering stockholder will receive payment with respect to purchased Shares, will be held for the tendering stockholder in an account created for the stockholder with ABIS, the Fund's transfer agent and agent designated for this purpose. Any subsequent payment on the Note will be made to the account specified in the stockholder's Notice of Intent to Tender.

------

We reserve the right, in our sole discretion, to change the Purchase Price and to increase or decrease the value of Shares sought in the Offer, subject to applicable law. See Sections 1, 3 and 4.

We expect to fund the principal amount of the Note in respect of any purchases of Shares pursuant to the Offer, including related fees and expenses, from available cash and/or borrowings under our revolving credit facility. The Offer is not conditioned upon the receipt of financing. See Section 8.

**How long do I have to tender my Shares?** 

You may tender your Shares until the Offer expires at 5:00 p.m., New York City time, on the Expiration Date, unless the Offer is extended or withdrawn. See Sections 1 and 3.

**Can the Offer be extended, amended or terminated and, if so, under what circumstances?** 

We can extend the Offer, in our sole discretion, at any time, subject to applicable laws. We may, however, decide not to extend the Offer. If we were to extend the Offer, we cannot indicate, at this time, the length of any extension that we may provide. If we extend the Offer, we will delay the acceptance of any Shares that have been tendered. We can also amend or terminate the Offer under certain circumstances. See Sections 6 and 14.

**How will I be notified if the Offer is extended, amended or terminated?** 

If the Offer is extended, we will issue a press release or other public announcement announcing the extension and the new expiration date no later than 9:00 a.m., New York City time, on the first business day after the previously scheduled expiration date. We will announce any other amendment to or termination of the Offer by promptly issuing a press release or other public announcement announcing the amendment or termination. See Section 14.

**What is the purpose of the Offer?** 

The Fund believes that the Offer represents an efficient way to return capital to stockholders who wish to receive cash for all or a portion of their Shares. The Offer also provides stockholders with an opportunity to obtain liquidity with respect to their Shares. In addition, stockholders who wish to achieve a greater percentage of equity ownership in the Fund will be able to do so by not tendering their Shares in the Offer. If the Fund completes the Offer, stockholders who retain all or a portion of their Shares will have a greater percentage ownership in the Fund and the potential to share in its future earnings and assets, while also bearing the attendant risks associated with owning Shares. See Section 2.

**If I participate in the Offer, will my outstanding capital commitments be affected?** 

The Fund is continuously offering Shares pursuant to commitments from stockholders ("***Capital Commitments***"). While all stockholders of the Fund may participate in this Offer, stockholders who entered into a Capital Commitment on or before February 27, 2023 that elect to tender Shares in the Offer by delivering a Notice of Intent will be electing a liquidity option and therefore that Capital Commitment will be released, except with respect to certain specified post-commitment obligations. Participation in the Offer by a stockholder that entered into a Capital Commitment after February 27, 2023 will have no effect on that Capital Commitment.

**What are the conditions to the Offer?** 

Our obligation to accept for payment and pay for Shares tendered in the Offer depends upon a number of conditions that must be satisfied or waived (to the extent permitted by law) on or prior to the Expiration Date, including that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no action, suit, proceeding or application by any government or governmental, regulatory or administrative
agency, authority or tribunal or by any other person, domestic, foreign or supranational, before any court, authority, agency, other tribunal or arbitrator or arbitration panel shall have been instituted or shall be pending, nor shall we have
received notice of any such action, that directly or indirectly (a) challenges or seeks to challenge, restrain, prohibit, delay or otherwise affect the making of the Offer, the acquisition by us of some or all of the Shares pursuant to the
Offer or otherwise relates in any manner to the Offer or seeks to obtain damages in respect of the Offer, (b) seeks to make the purchase of, or payment for, some or all of the Shares pursuant to the Offer illegal or may result in a delay in our
ability to accept for payment or pay for some or all of the Shares, (c) otherwise could reasonably be expected to materially adversely affect the business, properties, assets, liabilities, capitalization, stockholders' equity, financial
condition, operations, results of operations or prospects of us or any of our subsidiaries or affiliates, or (d) otherwise, in our reasonable judgment, could reasonably be expected to adversely affect us or any of our subsidiaries or affiliates
or the value of our Shares;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our acceptance for payment, purchase or payment for any Shares tendered in the Offer shall not violate or
conflict with, or otherwise be contrary to, any applicable law, statute, rule, regulation, decree or order;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no action shall have been taken nor any statute, rule, regulation, judgment, decree, injunction or order
(preliminary, permanent or otherwise) shall have been proposed, sought, enacted, entered, promulgated, enforced or deemed to be applicable to the Offer or us or any of our subsidiaries by any court, other tribunal, government or governmental agency
or other regulatory or administrative authority or body, domestic or foreign, which (a) indicates that any approval, waiver or other action of any such court, other tribunal, agency, authority or body may be required in connection with the
Offer or the purchase of Shares thereunder and which has not been obtained or taken, as applicable, (b) is reasonably likely to make the purchase of, or payment for, some or all of the Shares pursuant to the Offer illegal or to prohibit,
restrict or delay consummation of the Offer, (c) materially impairs, in our reasonable judgment, the contemplated benefits to us of the Offer, (d) seeks to impose limitations on our or our affiliates' ability to acquire or hold or to
exercise full rights of ownership, including, but not limited to, the right to vote their Shares on all matters validly presented to our stockholders, or (e) otherwise could reasonably be expected to materially adversely affect the business,
properties, assets, liabilities, capitalization, stockholders' equity, condition (financial or otherwise), operations, licenses, franchises, permits, permit applications, results of operations or prospects of us or any of our subsidiaries or
affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no general suspension of trading in, or limitation on prices for, securities on any U.S. national securities
exchange or in the over-the-counter market, declaration of a banking moratorium or any suspension of payments in respect of banks in the United States, whether or not
mandatory, or any limitation, whether or not mandatory, by any governmental, regulatory or administrative agency, authority or body on, or any event that is likely, in our reasonable judgment, to materially adversely affect, the extension of credit
by banks or other lending institutions in the United States (or if existing at the time of commencement of the Offer, a material worsening thereof) shall have occurred;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no commencement or escalation, on or after February 27, 2026, of war, armed hostilities or other
international or national calamity, including, but not limited to, an act of terrorism, directly or indirectly involving the United States or any other jurisdiction in which AB PCIC or any of its subsidiaries maintains an office or conducts business
(or if existing at the time of commencement of the Offer, a material worsening thereof) shall have occurred;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no change, condition, event or development or any condition, event or development involving a prospective change,
in general political, market, economic, financial or industry conditions in the United States or internationally that, in our reasonable judgment, has, or could reasonably be expected to have, a material adverse effect on the business, properties,
assets, liabilities, capitalization, stockholders' equity, condition (financial or otherwise), operations, licenses, franchises, permits, permit applications, results of operations or prospects of AB PCIC and its subsidiaries, taken as a
whole, on the value of or trading in the Shares, on our ability to consummate the Offer or on the benefits of the Offer to us (or if existing at the time of commencement of the Offer, a material worsening thereof), shall have occurred;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no change, condition, event or development (including any act of nature or man-made disaster) or any condition, event or development involving a prospective change, in the business, properties, assets, liabilities, capitalization, stockholders' equity, condition (financial or
otherwise), operations, licenses, franchises, permits, permit applications, results of operations or prospects of AB PCIC or any of its subsidiaries that, in our reasonable judgment, has, or could reasonably be expected to have, a material adverse
effect on AB PCIC and its subsidiaries, taken as a whole, on the value of or trading in the Shares, on our ability to consummate the Offer or on the benefits of the Offer to us (or if existing at the time of commencement of the Offer, a material
worsening thereof), shall have occurred;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no decrease or increase of more than 10% in the Dow Jones Industrial Average, New York Stock Exchange Index,
NASDAQ Composite Index, the Standard and Poor's 500 Composite Index or the Wells Fargo Business Development Company Index measured from the close of trading on February 27, 2026 shall have occurred;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no tender or exchange offer for any or all of the outstanding Shares, or any merger, acquisition, business
combination or other similar transaction with or involving AB PCIC or any of its subsidiaries, shall have been proposed, announced or made by any person or entity or shall have been publicly disclosed, nor shall we have entered into a definitive
agreement or an agreement in principle with any person with respect to a merger, acquisition, business combination or other similar transaction, in each case, other than the Offer or otherwise described herein;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we shall not have become aware that any entity, "group" (as that term is used in
Section 13(d)(3) of the Securities Exchange Act of 1934, as amended (the "  ***Exchange Act*** ")) or person (a) has acquired or proposes to acquire beneficial ownership of more than 5% of the outstanding Shares, whether
through the acquisition of stock, the formation of a group, the grant of any option or right (options for and other rights to acquire Shares that are acquired or proposed to be acquired being deemed to be immediately exercisable or convertible for
purposes of this clause), or otherwise (other than by virtue of consummation of the Offer or anyone who publicly disclosed such ownership in a filing with the SEC on or before February 27, 2026), (b) who has filed a Schedule 13D or Schedule 13G
with the SEC on or before February 27, 2026, has acquired or proposes to acquire, whether through the acquisition of Shares, the formation of a group, the grant of any option or right (options for and other rights to acquire Shares that are
acquired or proposed to be acquired being deemed

------

to be immediately exercisable or convertible for purposes of this clause), or otherwise (other than by virtue of consummation of the Offer), beneficial ownership of an additional 1% or more of the outstanding Shares or (c) shall have filed a Notification and Report Form under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, reflecting an intent to acquire us or any of our subsidiaries or any of our or any of our subsidiaries' assets or securities; <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• no approval, permit, authorization, favorable review or consent or waiver of or filing with any domestic or
foreign governmental or regulatory authority, agency or body or any third party consent or notice, required to be obtained or made in connection with the Offer shall not have been obtained or made on terms and conditions satisfactory to us in our
reasonable judgment; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we do not determine, in our reasonable judgment, that the consummation of the Offer or the purchase of Shares
from any stockholder could jeopardize our qualification and taxation as a regulated investment company ("  ***RIC***") under Subchapter M of the Internal Revenue Code of 1986, as amended, for U.S. federal income tax purposes.

The Offer is subject to these conditions, all of which are also described in Section 6. Each of these conditions is for our sole benefit and may be asserted or waived by us, in whole or in part, at any time and from time to time in our discretion prior to the Expiration Date. In certain circumstances, if we waive any of the conditions described above, we may be required to extend the Expiration Date. The Offer is not conditioned upon the receipt of financing or any minimum number of Shares being tendered.

**How do I tender my Shares?** 

If you want to tender all or any portion of your Shares, you must complete and sign the Notice of Intent according to its instructions and mail (via certified mail return receipt requested), email, fax or hand deliver it, together with any other documents required by the Notice of Intent, to your financial advisor prior to the Expiration Date. If you do not have a Bernstein financial advisor, you should send the Notice of Intent and any other documents required by the Notice of Intent to ABIS at the following address: 66 Hudson Boulevard East, Attn: Private Client, New York, NY 10001, fax no. (212) 407-5850, so that it is received prior to the Expiration Date. If you choose to fax the Notice of Intent, you should mail the original Notice of Intent promptly after it is faxed (the original does not have to be received before the deadline). See Section 3.

We recommend that you consult your financial advisor to determine the status of your account and the best way to tender your Shares. If you have any questions related to the status of the Shares in your registered account, or need to confirm the number of Shares held in your registered account, please contact your financial advisor. If you have any questions related to how that status impacts how you may tender your Shares, please contact ABIS at (212) 969-1000. See Section 3 and the instructions to the Notice of Intent.

**The method of delivery of all documents, including the Notice of Intent and any other required documents, is at the sole election and risk of the tendering stockholder. Shares will be deemed delivered only when actually received by your financial advisor or ABIS, as applicable. If delivery is by mail, then registered mail with return receipt requested, properly insured, is recommended. In all cases, sufficient time should be allowed to ensure timely delivery.** 

**IF YOU WANT TO TENDER ANY PORTION OF YOUR SHARES, YOU MUST DELIVER THE NOTICE OF INTENT AND OTHER REQUIRED DOCUMENTS TO YOUR FINANCIAL ADVISOR OR ABIS. ANY DOCUMENTS DELIVERED TO THE FUND OR ANY OTHER PERSON WILL NOT BE FORWARDED TO YOUR FINANCIAL ADVISOR AND WILL NOT BE DEEMED TO BE PROPERLY TENDERED.** 

**Has the Board of Directors or AB PCIC adopted a position on the Offer?** 

In considering the Offer, our Board of Directors reviewed, with the assistance of management and professional advisors, the Fund's results of operations, financial position and capital requirements, general business conditions, legal, regulatory and contractual constraints and restrictions and other factors our Board of Directors deemed relevant. Following such review, our Board of Directors determined that the Offer is a prudent use of the Fund's financial resources and authorized the Offer. However, none of the Fund, any member of our Board of Directors, AB Private Credit Investors LLC, the Fund's investment adviser ("***AB PCI***"), or any of their respective affiliates has made, or is making, any recommendation to you as to whether you should tender or refrain from tendering your Shares. You must make your own decision as to whether to tender your Shares and how many Shares to tender. In doing so, you should read carefully the information in or incorporated by reference in this Offer to Purchase and the Notice of Intent, including the purposes and effects of the Offer. You are urged to discuss your decision with your financial advisor and/or tax advisor. See Section 2.

**What happens if the number of Shares tendered in the Offer exceeds the Quarterly Tender Cap?** 

The Fund is not required to purchase Shares in excess of the Quarterly Tender Cap. If stockholders attempt to tender in excess of the Quarterly Tender Cap, the Fund will either (a) purchase Shares from all stockholders who properly tender Shares, on a pro rata basis, until it has purchased Shares resulting in an aggregate of 2.5% of the weighted average of the number of Shares outstanding during the

------

three-month period ended December 31, 2025 or (b) extend the Expiration Date and increase the maximum amount of Shares that it is offering to purchase in the Offer. See Sections 1, 3, 4 and 5. In accordance with rules promulgated by the Securities and Exchange Commission, the Fund may increase the number of Shares accepted for payment in the Offer by up to, but not more than, 2% of the outstanding Shares without amending or extending the Offer.

As a result of the Quarterly Tender Cap, the Fund will not be required to purchase an aggregate number of Shares in the Offer in excess of 1,861,300.28 Shares.

Because of the cutback provisions described above, it is possible that we will not purchase all of the Shares that you tender.

**Once I have tendered Shares in the Offer, can I withdraw my tender?** 

Yes. You may withdraw your tendered Shares at any time prior to the Expiration Date, or such later time and date to which we may extend the Offer. In addition, unless we have already accepted your tendered Shares for payment, you may withdraw your tendered Shares at any time at or after 12:01 a.m., New York City time, on April 23, 2026. See Section 4.

**How do I withdraw Shares previously tendered?** 

To properly withdraw your previously tendered Shares, you must deliver (by email, facsimile, regular mail, overnight courier or hand delivery), prior to the Expiration Date, a properly completed and duly executed Notice of Withdrawal ("***Notice of Withdrawal***") attached as Exhibit (a)(1)(C) to the Tender Offer Statement on Schedule TO (the "***Schedule TO***"). To obtain a Notice of Withdrawal, please contact your financial advisor. If you do not have a Bernstein financial advisor, please contact ABIS at (212) 969-1000. See Section 4.

**What will happen if I do not tender my Shares?** 

Stockholders who do not participate in the Offer will retain their Shares and, if the Fund completes the Offer, their relative ownership interest in the Fund will automatically increase. In addition, such stockholders will continue to be required to make capital contributions to purchase Shares each time the Fund delivers a capital call notice. See Section 2.

**When and how will AB PCIC pay for my tendered Shares that are accepted for payment pursuant to the Offer?** 

For each stockholder who tenders Shares that are accepted for purchase, payment of the Purchase Price will consist of a Note entitling the stockholder to receive a cash payment in an amount per Share equal to the net asset value of such Shares, determined as of March 31, 2026. Payment of this amount will be made to you approximately 45 days after the Expiration Date.

We will announce the preliminary results of the Offer, including preliminary information about any expected cutbacks, and deliver the Notes to stockholders, promptly after the Expiration Date. We will pay the cash payments in respect of the Notes, less any applicable withholding taxes and without interest, for the Shares we accepted for payment, approximately 45 days after the Expiration Date. In the event of cutbacks, the Fund will determine the cutback factor and deliver the Notes for those tendered Shares accepted for payment promptly after the Expiration Date. We will pay for the Shares accepted for payment by depositing the aggregate purchase price in cash to your account designated on the Notice of Intent approximately 45 days after the Expiration Date in full repayment of your Note, at which point the Note will be cancelled. See Section 5.

**What is the market price for the Shares?** 

The Shares are not currently traded on an established trading market. We can give no assurance as to the price at which stockholders may be able to sell Shares in the future. On the other hand, Shares properly tendered and accepted for payment and paid for will no longer entitle the former owners to participate in the performance of the Fund as evidenced by any Share price or net asset value appreciation (or depreciation) and any payment of distributions on the Shares.

**Will I have to pay brokerage fees and commissions if I tender my Shares?** 

If you are a holder of record of your Shares and you tender your Shares directly to your financial advisor (or, if you do not have a Bernstein financial advisor, to ABIS), you will not incur any brokerage fees or commissions. See Section 3.

**What is the accounting treatment of the Offer?** 

The purchase of Shares pursuant to the Offer will initially result in a reduction of our stockholders' equity in an amount equal to the aggregate purchase price of the Shares we purchase and a corresponding increase in our liabilities due to the Notes. Payment of the Notes will result in a reduction in total cash and cash equivalents, depending on the source of funding, and a corresponding decrease in our liabilities due to the cancellation of the Notes. See Section 15.

------

**Are there any governmental or regulatory approvals, consents or filings to be made or obtained in connection with the Offer?** 

We are not aware of any other approval or other action by any governmental, administrative or regulatory authority, agency or body, domestic, foreign or supranational, that would be required for our acquisition or ownership of Shares as contemplated by the Offer. Should any such approval or other action or notice filings be required, we presently contemplate that we will seek that approval or other action and make or cause to be made such notice filings. We cannot predict whether we will be required to delay the acceptance for payment of or payment for Shares tendered in the Offer pending the outcome of any such approval or other action. There can be no assurance that any such approval or other action, if needed, would be obtained or would be obtained without substantial cost or conditions or that the failure to obtain the approval or other action might not result in adverse consequences to our business and financial condition. Our obligations pursuant to the Offer to accept for payment and pay for Shares are subject to the satisfaction of certain conditions. See Sections 6 and 12.

**What are the material U.S. federal income tax consequences if I tender my Shares?** 

Generally, if you are a U.S. Holder (as defined in Section 13), the sale of Shares pursuant to the Offer will be a taxable event for U.S. federal income tax purposes. The receipt of the cash payment in respect of the Note received for your tendered Shares will generally be treated for U.S. federal income tax purposes either as (a) proceeds from a sale or exchange generally eligible for capital gain or loss treatment or (b) a distribution in respect of stock from the Fund. If you are a U.S. Holder, you should complete Internal Revenue Service ("***IRS***") Form W-9 included as part of the Notice of Intent. Any tendering stockholder or other payee who is a U.S. Holder and who fails to timely complete, sign and return to its financial advisor, or, if the stockholder or other payee does not have a Bernstein financial advisor, to ABIS, the IRS Form W-9 included in the Notice of Intent (or such other IRS form as may be applicable) may be subject to U.S. backup withholding tax. See Section 3. Non-U.S. Holders (as defined in Section 13) are urged to consult their tax advisors regarding the applicability of U.S. federal income tax withholding, including eligibility for a withholding tax reduction or exemption and the refund procedure, upon the cash payment received in respect of the Note in exchange for Shares. All stockholders should review the discussion in Sections 3 and 13 regarding material U.S. federal income tax consequences and consult their tax advisor regarding the tax consequences of the Offer.

**Will I have to pay a stock transfer tax if I tender my Shares?** 

If you instruct the Fund in the Notice of Intent to make the payment for the tendered Shares to the registered holder, you will not incur any stock transfer tax for any Shares that are accepted in the Offer. See Section 5.

**Whom do I contact if I have questions about the Offer?** 

Questions and requests for assistance by stockholders may be directed to your financial advisor. If you do not have a Bernstein financial advisor, you may contact ABIS at (212) 969-1000. You may request additional copies of this Offer to Purchase, the Notice of Intent and the other documents related to the Offer from your financial advisor, or, if you do not have a Bernstein financial advisor, from ABIS at (212) 969-1000. Such additional copies of these materials will be promptly furnished to stockholders at the Fund's expense.

**FORWARD-LOOKING STATEMENTS** 

**Cautionary Note Regarding Forward-Looking Statements** 

This Offer to Purchase may include forward-looking statements. Words like "anticipate," "believe," "expect" and "intend" indicate a forward-looking statement, although not all forward-looking statements include these words. Although we believe that the expectations reflected in such forward-looking statements are based upon reasonable assumptions, our actual results could differ materially from those set forth in the forward-looking statements. These beliefs, expectations and assumptions are subject to risks and uncertainties and can change as a result of many possible events or factors, not all of which are known to us. If a change occurs, our business, financial condition, liquidity and results of operations may vary materially from those expressed in our forward-looking statements. You should carefully consider these risks before you make an investment decision with respect to our Shares, along with the following factors that could cause actual results to vary from our forward-looking statements:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• changes in the economy;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• risks associated with possible disruption in our operations or the economy generally due to terrorism, natural
disasters, pandemics or other serious public health events, such as the recent global outbreak of a novel strain of the coronavirus, commonly known as COVID-19;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• future changes in laws or regulations and conditions in our industry; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the ability to complete the Offer.

------

Except as required by the federal securities laws, we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised to consult any additional disclosures that we may make directly to you or through reports that we may file in the future with the SEC, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. The forward-looking statements and projections contained in this Offer to Purchase are excluded from the safe harbor protection provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act.

**INTRODUCTION** 

To the Stockholders of AB Private Credit Investors Corporation:

AB Private Credit Investors Corporation (the "***Fund***," "***AB PCIC***," "***we***" or "***us***") invites its stockholders to tender their shares of its common stock, par value $0.01 per share (the "***Shares***") for purchase by the Fund. Upon the terms and subject to the conditions of this Offer to Purchase, dated February 27, 2026 (this "***Offer to Purchase***"), and the related Notice of Intent to Tender (the "***Notice of Intent***," which, together with the Offer to Purchase, as each may be amended or supplemented from time to time, constitute the "***Offer***"), we are offering to purchase for cash on the terms and conditions set out in this Offer to Purchase up to 1,861,300.28 Shares pursuant to tenders at a price per Share equal to our net asset value per Share as of March 31, 2026 (the "***Purchase Price***," and such date, as it may be extended, the "***Expiration Date***").

**The Offer will expire at 5:00 p.m., New York City time, on the Expiration Date, unless the Offer is extended or withdrawn. To tender your Shares, you must follow the procedures described in this Offer to Purchase, the Notice of Intent and the other documents related to the Offer.** 

The Fund is offering to purchase up to 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025 (the "***Quarterly Tender Cap***"). The Fund is not required to purchase any tendered Shares in excess of the Quarterly Tender Cap and, therefore, the Fund is not required to purchase any tendered Shares to the extent those Shares are, in the aggregate, in excess of 1,861,300.28.

The Fund is continuously offering Shares pursuant to commitments from stockholders ("***Capital Commitments***"). While all stockholders of the Fund may participate in this Offer, stockholders who entered into a Capital Commitment on or before February 27, 2023 that elect to tender Shares in the Offer by delivering a Notice of Intent will be electing a liquidity option and therefore that Capital Commitment will be released, except with respect to certain specified post-commitment obligations. Participation in the Offer by a stockholder that entered into a Capital Commitment after February 27, 2023 will have no effect on that Capital Commitment.

We will not accept Shares subject to conditional tenders, such as acceptance of all or none of the Shares tendered by any tendering stockholder. If any tendered Shares are not purchased for any reason, the Notice of Intent with respect to such Shares not purchased will be of no force or effect. Shares tendered but not purchased pursuant to the Offer will be returned promptly following the Expiration Date. See Sections 3 and 4.

Subject to the applicable rules and regulations promulgated by the Securities and Exchange Commission (the "***SEC***"), we expressly reserve the right, in our sole discretion, at any time and from time to time, (a) to extend the period of time during which the Offer is open and thereby delay acceptance for payment of, and the payment for, any Shares, subject to the restrictions below, (b) to increase or decrease the value of Shares sought in the Offer, (c) to amend the Offer in any respect prior to the Expiration Date and (d) if any condition specified in Section 6 is not satisfied or waived prior to the Expiration Date, to terminate the Offer and not accept any Shares for payment. Notice of any such extension, amendment or termination will be distributed promptly to stockholders in a manner reasonably designed to inform them of such change in compliance with Rule 13e-4(e)(3) promulgated under the Securities Exchange Act of 1934, as amended (the "***Exchange Act***"). In the case of an extension of the Offer, such extension will be followed by a press release or other public announcement, which will be issued no later than 9:00 a.m., New York City time, on the next business day after the scheduled Expiration Date, in accordance with Rule 14e-1(d) promulgated under the Exchange Act. See Sections 1, 3, 4 and 14.

THE OFFER IS NOT CONDITIONED UPON THE RECEIPT OF FINANCING OR ANY MINIMUM NUMBER OF SHARES BEING TENDERED. THE OFFER IS, HOWEVER, SUBJECT TO A NUMBER OF OTHER TERMS AND CONDITIONS. SEE SECTION 6.

ALTHOUGH OUR BOARD OF DIRECTORS HAS AUTHORIZED THE OFFER, NONE OF THE FUND, ANY MEMBER OF OUR BOARD OF DIRECTORS, AB PCI (EACH AS DEFINED HEREIN) OR ANY OF THEIR RESPECTIVE AFFILIATES HAS MADE, OR IS MAKING, ANY RECOMMENDATION TO YOU AS TO WHETHER TO TENDER OR REFRAIN FROM TENDERING YOUR SHARES. YOU MUST MAKE YOUR OWN DECISION AS TO WHETHER TO TENDER YOUR SHARES AND HOW MANY SHARES TO TENDER. IN DOING SO, YOU SHOULD READ CAREFULLY THE INFORMATION IN OR INCORPORATED BY REFERENCE IN THIS OFFER TO PURCHASE AND THE NOTICE OF INTENT, INCLUDING THE PURPOSES AND EFFECTS OF THE OFFER. SEE SECTION 2. YOU ARE URGED TO DISCUSS YOUR DECISION WITH YOUR FINANCIAL ADVISOR AND/OR TAX ADVISOR.

------

Upon the terms and subject to the conditions of the Offer, if stockholders attempt to tender in excess of the Quarterly Tender Cap, we will either (a) purchase Shares from all stockholders who properly tender Shares, on a pro rata basis, with appropriate adjustments to avoid the purchase of fractional Shares, until we have purchased Shares resulting in an aggregate of 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025 or (b) extend the Expiration Date and increase the maximum amount of Shares that we are offering to purchase in the Offer. See Sections 1, 3, 4 and 5. In accordance with rules promulgated by the SEC, we may increase the number of Shares accepted for payment in the Offer by up to, but not more than, 2% of the outstanding Shares without amending or extending the Offer. Because of the cutback provisions described above, we may not purchase all of the Shares that you tender. See Section 1.

If you tender Shares and we purchase those Shares, we will issue you a non-interest bearing, non-transferrable promissory note (a "***Note***") entitling you to an amount in cash equal to the number of your Shares accepted for purchase multiplied by the Purchase Price, payable approximately 45 days after the Expiration Date. The Note will be held for you in an account with ABIS, the Fund's transfer agent and agent designated for this purpose. If you wish to receive a copy of your Note, you may contact your Bernstein financial advisor or the Fund at (212) 969-1000, Monday through Friday, except holidays, during normal business hours of 9:00 a.m. to 5:00 p.m., New York time, to request that a copy be sent to you by mail.

Also, any tendering stockholder or other payee who is a U.S. Holder (as defined in Section 13) and who fails to timely complete, sign and return to its financial advisor, or, if such stockholder or other payee does not have a Bernstein financial advisor, to ABIS, the Internal Revenue Service ("***IRS***") Form W-9 included with the Notice of Intent (or such other IRS form as may be applicable), may be subject to U.S. federal backup withholding tax on the gross proceeds paid to the U.S. Holder pursuant to the Offer. See Section 3. Also, see Section 13 regarding the material U.S. federal income tax consequences of the Offer.

The Shares are not currently traded on an established trading market. We can give no assurance as to the price at which stockholders may be able to sell Shares in the future. On the other hand, Shares properly tendered and accepted for payment and paid for will no longer entitle the former owners to participate in the performance of the Fund as evidenced by any Share price or net asset value appreciation (or depreciation) and any payment of distributions on the Shares. See Section 7.

As of December 31, 2025, there were 77,076,615 issued and outstanding Shares, and as of February 27, 2026, there were 77,076,221 issued and outstanding Shares. If the Offer is fully subscribed, we could purchase 1,861,300.28 Shares, which would represent 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025. See Section 1.

References in this Offer to Purchase to "dollars" and "$" are to the lawful currency of the United States of America.

**This Offer to Purchase and Notice of Intent contain important information, and you should carefully read both in their entirety before you make a decision with respect to the Offer.** 

**THE OFFER** 

**1. Number of Shares; Purchase Price; Cutbacks** 

*General*. Upon the terms and subject to the conditions of the Offer, we are offering to purchase up to 1,861,300.28 Shares (which is equal to 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025) pursuant to tenders at a price per Share equal to the Purchase Price as of March 31, 2026. The Fund is not required to purchase any Shares properly tendered and not properly withdrawn in excess of the Quarterly Tender Cap. The Fund is extending this offer to all stockholders of the Fund as of February 27, 2026 with respect to all of the Shares owned by such stockholder as of February 27, 2026.

If you tender Shares and we purchase those Shares, we will issue you a Note entitling you to an amount in cash equal to the number of your Shares accepted for purchase multiplied by the Purchase Price, payable approximately 45 days after the Expiration Date. The Note will be held for you in an account with ABIS, the Fund's transfer agent and agent designated for this purpose. If you wish to receive a copy of your Note, you may contact your Bernstein financial advisor or the Fund at (212) 969-1000, Monday through Friday, except holidays, during normal business hours of 9:00 a.m. to 5:00 p.m., New York time, to request that a copy be sent to you by mail.

The Offer will expire on the Expiration Date, unless the Offer is extended or withdrawn. To tender your Shares you must follow the procedures described in this Offer to Purchase, the Notice of Intent and the other documents related to the Offer.

------

Only Shares properly tendered, and not properly withdrawn, will be purchased. However, because of the cutback provisions described in this Offer to Purchase, all of the Shares properly tendered and not properly withdrawn may not be purchased if those Shares are, in the aggregate, in excess of the Quarterly Tender Cap. All Shares tendered and not purchased in the Offer, including Shares not purchased because of cutbacks, will be returned to the tendering stockholders at our expense promptly following the Expiration Date.

We will not accept Shares subject to conditional tenders, such as acceptance of all or none of the Shares that are tendered by any tendering stockholder.

If we increase or decrease the Purchase Price or decrease the number of Shares that we may purchase in the Offer, then the Offer must remain open for at least 10 business days following the date that notice of the increase or decrease is first published, sent or given in the manner specified in Section 14. In accordance with rules promulgated by the SEC, we may increase the number of Shares accepted for payment in the Offer by up to, but not more than, 2% of the outstanding Shares without amending or extending the Offer.

Stockholders properly tendering Shares can reasonably expect to have at least a portion of such Shares purchased if any Shares are purchased pursuant to the Offer (subject to provisions relating to cutbacks described in this Offer to Purchase).

Shares acquired pursuant to the Offer will be acquired by AB PCIC free and clear of all liens, charges, encumbrances, security interests, claims, restrictions and equities whatsoever, together with all rights and benefits arising therefrom, provided that any distributions which may be declared, paid, issued, distributed, made or transferred on or in respect of such Shares to stockholders of record on or prior to the date on which the Shares are accepted for payment pursuant to the Offer shall be for the account of such stockholders.

The Offer is not conditioned upon the receipt of financing or any minimum number of Shares being tendered. The Offer is, however, subject to a number of other terms and conditions. See Section 6.

*Capital Commitments*. The Fund is continuously offering Shares pursuant to Capital Commitments. While all stockholders of the Fund may participate in this Offer, stockholders who entered into a Capital Commitment on or before February 27, 2023 that elect to tender Shares in the Offer by delivering a Notice of Intent will be electing a liquidity option and therefore that Capital Commitment will be released, except with respect to certain specified post-commitment obligations. Participation in the Offer by a stockholder that entered into a Capital Commitment after February 27, 2023 will have no effect on that Capital Commitment.

*Cutbacks*. Upon the terms and subject to the conditions of the Offer, if stockholders attempt to tender in excess of the Quarterly Tender Cap, we will either (a) purchase Shares from all stockholders who properly tender Shares, on a pro rata basis, until we have purchased Shares resulting in an aggregate of 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025 or (b) extend the Expiration Date and increase the maximum amount of Shares that we are offering to purchase in the Offer. See Sections 1, 3, 4 and 5. In accordance with rules promulgated by the SEC, we may increase the number of Shares accepted for payment in the Offer by up to, but not more than, 2% of the outstanding Shares without amending or extending the Offer. Because of the cutback provisions described above, we may not purchase all of the Shares that you tender. See Section 1.

As a result of the cutbacks applicable to the purchase of Shares tendered, it is possible that not all of the Shares that a stockholder tenders in the Offer will be purchased. In addition, if a tender is conditioned upon the purchase of a specified number of Shares, none of those Shares will be purchased.

If any cutback of tendered Shares is required, the Fund will determine the cutback factor promptly following the Expiration Date. Cutbacks for each stockholder tendering Shares will be based on the ratio of the number of Shares properly tendered and not properly withdrawn by a stockholder to the total number of Shares properly tendered and not properly withdrawn by all stockholders in the Offer. In the event of cutbacks, the Fund will determine the cutback factor and deliver the Notes for those tendered Shares accepted for payment promptly after the Expiration Date. The preliminary results of cutbacks, if any, will be announced promptly after the Expiration Date. After the Expiration Date, stockholders may obtain preliminary cutback information from their financial advisor, or, if the stockholder does not have a Bernstein financial advisor, from ABIS, and also may be able to obtain the information from their brokers.

As described in Section 13, the extent to which a stockholder's Shares are purchased pursuant to the Offer may affect the U.S. federal income tax consequences of the purchase to the stockholder and, therefore, may be relevant to a stockholder's decision whether to tender Shares. **All stockholders should review the discussion in Sections 3 and 13 regarding material U.S. federal income tax consequences and consult their tax advisor regarding the tax consequences of the Offer**.

This Offer to Purchase and the Notice of Intent will be mailed to record holders of the Shares upon request.

We are not aware of any jurisdiction where the making of the Offer is prohibited by any administrative or judicial action pursuant to any valid state statute. If we become aware of any valid state statute prohibiting the making of the Offer or the acceptance of the Shares, we will make a good faith effort to comply with that state statute or seek to have such statute declared inapplicable to the Offer. If, after

------

a good faith effort, we cannot comply with the state statute, we will not make the Offer to, nor will we accept tenders from or on behalf of, the holders of Shares in that state. In any jurisdiction where the securities, blue sky or other laws require the Offer to be made by a licensed broker or dealer, the Offer shall be deemed to be made on our behalf by one or more registered brokers or dealers licensed under the laws of that jurisdiction.

**2. Purpose of the Offer; Certain Effects of the Offer; Plans or Proposals** 

**Purpose of the Offer** 

The Offer provides stockholders with an opportunity to obtain liquidity with respect to their Shares. The Fund further believes that the Offer represents an efficient way to return capital to stockholders who wish to receive cash for their Shares. In addition, stockholders who wish to achieve a greater percentage of equity ownership in the Fund will be able to do so by not tendering their Shares in the Offer. If the Fund completes the Offer, stockholders who retain all or a portion of their Shares will have a greater percentage ownership in the Fund and the potential to share in its future earnings and assets, while also bearing the attendant risks associated with owning Shares.

**ALTHOUGH OUR BOARD OF DIRECTORS HAS AUTHORIZED THE OFFER, NONE OF THE FUND, ANY MEMBER OF OUR BOARD OF DIRECTORS, AB PCI OR ANY OF THEIR RESPECTIVE AFFILIATES MADE, OR IS MAKING, ANY RECOMMENDATION TO YOU AS TO WHETHER TO TENDER OR REFRAIN FROM TENDERING YOUR SHARES. WE HAVE NOT AUTHORIZED ANY PERSON TO MAKE ANY SUCH RECOMMENDATION. YOU MUST MAKE YOUR OWN DECISION AS TO WHETHER TO TENDER YOUR SHARES AND HOW MANY SHARES TO TENDER. IN DOING SO, YOU SHOULD READ CAREFULLY THE INFORMATION IN OR INCORPORATED BY REFERENCE IN THIS OFFER TO PURCHASE AND THE NOTICE OF INTENT, INCLUDING THE PURPOSES AND EFFECTS OF THE OFFER. YOU ARE URGED TO DISCUSS YOUR DECISION WITH YOUR FINANCIAL ADVISOR AND/OR TAX ADVISOR.** 

**Certain Effects of the Offer** 

Stockholders who do not tender their Shares in the Offer and stockholders who otherwise retain an equity interest in the Fund as a result of a partial tender of Shares or cutbacks will continue to be owners of the Fund. Stockholders who wish to achieve a greater percentage of equity ownership in the Fund will be able to do so by not tendering their Shares in the Offer. If the Fund completes the Offer, stockholders who retain all or a portion of their Shares will have a greater percentage ownership in AB PCIC and the potential to share in its future earnings and assets, while also bearing the attendant risks associated with owning Shares.

The Shares are subject to certain restrictions on transfer, as fully set forth in each investor's separate subscription agreement with the Fund. Nonetheless, it is possible that stockholders may be able to sell non-tendered Shares in the future at a net price significantly higher or lower than the Purchase Price. We can give no assurance as to the price at which stockholders may be able to sell Shares in the future. On the other hand, Shares properly tendered and accepted for payment and paid for will no longer entitle the former owners to participate in the performance of the Fund as evidenced by any Share price appreciation (or depreciation) and any payment of distributions on the Shares.

None of our executive officers own Shares of the Fund at this time, and none of our directors intend to tender any of their Shares in the Offer. To our knowledge, the Fund's affiliates that own Shares do not intend to tender any of their Shares in the Offer. Therefore, the Offer will increase the proportional holdings of our directors and affiliates.

The Fund's class of Shares is registered under the Exchange Act, which requires, among other things, that we furnish certain information to our stockholders and the SEC and comply with the SEC's proxy rules in connection with meetings of our stockholders. We believe that our purchase of Shares pursuant to the Offer will not result in the deregistration of the class of Shares under the Exchange Act. The Offer is conditioned upon, among other things, our having determined in our reasonable judgment that the consummation of the Offer will not cause the class of Shares to be eligible for deregistration under the Exchange Act. See Section 6.

Shares we acquire pursuant to the Offer will no longer be outstanding and will constitute authorized but unissued shares of capital stock of the Fund. Rule 13e-4 promulgated under the Exchange Act prohibits us and our affiliates from purchasing any Shares, other than pursuant to the Offer, until at least 10 business days following the Expiration Date.

The purchase of Shares pursuant to the Offer will result in a reduction of our stockholders' equity in an amount equal to the aggregate purchase price of the Shares we purchase and a corresponding increase in liabilities and/or reduction in total cash and cash equivalents depending on the source of funding. After the Offer is completed, we believe that our capital structure, including the available balance of our financing facilities and cash flow from operations, will provide us with sufficient liquidity to meet our current operating expenses and other expenses directly associated with our business for the foreseeable future. However, actual experience may differ significantly from our expectations. See "***Forward-Looking Statements***." In considering the Offer, our management and our Board of Directors took into account the expected financial impact of the Offer.

------

**Plans or Proposals** 

Except as disclosed or incorporated by reference in this Offer to Purchase, AB PCIC currently has no plans, proposals or negotiations underway that relate to or would result in:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any extraordinary transaction, such as a merger, reorganization or liquidation, involving AB PCIC or any of its
subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any purchase, sale or transfer of a material amount of assets of AB PCIC or any of its subsidiaries;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any material change in the present distribution rate or policy or capitalization of AB PCIC;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any change in the present Board of Directors or management of AB PCIC, including, but not limited to, any plans
or proposals to change the number or the term of directors or to fill any existing vacancies on the Board of Directors or to change any material term of the employment contract of any executive officer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any other material change in AB PCIC's corporate structure or business;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any class of equity securities of AB PCIC becoming eligible for termination of registration under
Section 12(g)(4) of the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the suspension of AB PCIC's obligation to file reports under Section 15(d) of the Exchange Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the acquisition by any person of additional securities of AB PCIC or the disposition by any person of securities
of AB PCIC; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any changes in AB PCIC's charter, bylaws or other governing instruments or other actions that could impede
the acquisition of control of AB PCIC.

The Fund currently expects to distribute a portion of its undistributed taxable income to stockholders in the form of quarterly cash distributions. Our Board of Directors intends to declare one quarterly cash distribution, in an aggregate amount of all of the net investment income of the Fund, as determined by the officers of the Fund, for the period January 1, 2026 through March 31, 2026, to stockholders of record on March 27, 2026. The payment of any quarterly cash distribution is subject to restrictions under applicable law and the sole discretion of our Board of Directors, and therefore, there can be no assurance as to the amount or timing of any such future distribution.

Although we do not currently have any plans, other than as disclosed or incorporated by reference in this Offer to Purchase, that relate to or would result in any of the events discussed above, we reserve the right to change our plans and intentions at any time as we deem appropriate. After completing the Offer, we may consider various forms of stock repurchases after taking into account the results of the Offer, our results of operations, financial position and capital requirements, general business conditions, legal, regulatory, rating agency and contractual constraints and restrictions and other factors our Board of Directors deems relevant. These purchases may be made from time to time on the open market or through privately-negotiated transactions, and may be on the same terms or on terms and prices that are more or less favorable to stockholders than the terms of this Offer.

**3. Procedures for Tendering Shares** 

*Proper Tenders of Shares*. You may tender your Shares in the Offer by delivering (by email, facsimile, regular mail, overnight courier or hand delivery) a properly completed and duly executed Notice of Intent (or an originally signed photocopy of the Notice of Intent), together with any other required documents, to your financial advisor, which must be received by your financial advisor before the Expiration Date. If you do not have a Bernstein financial advisor, the Notice of Intent, together with any other required documents, should be sent to ABIS at the following address: 66 Hudson Boulevard East, Attn: Private Client, New York, NY 10001, fax no. (212) 407-5850.

*Method of Delivery*. In all cases, payment for Shares tendered and accepted for payment pursuant to the Offer will be made only after timely receipt by the financial advisor or ABIS of a properly completed and duly executed Notice of Intent (or an originally signed photocopy of the Notice of Intent), and any other documents required by the Notice of Intent. The method of delivery of all documents, including the Notice of Intent and any other required documents, is at the sole election and risk of the tendering stockholder. Shares will be deemed delivered only when actually received by your financial advisor or ABIS. If delivery is by mail, then registered mail with return receipt requested, properly insured, is recommended. In all cases, sufficient time should be allowed to ensure timely delivery.

------

IF YOU WANT TO TENDER ALL OR A PORTION OF YOUR SHARES, YOU MUST DELIVER THE NOTICE OF INTENT AND OTHER REQUIRED DOCUMENTS TO YOUR FINANCIAL ADVISOR, OR, IF YOU DO NOT HAVE A BERNSTEIN FINANCIAL ADVISOR, TO ABIS. ANY DOCUMENTS DELIVERED TO US OR ANY OTHER PERSON WILL NOT BE FORWARDED TO YOUR FINANCIAL ADVISOR AND WILL NOT BE DEEMED TO BE PROPERLY TENDERED.

*Return of Unpurchased Shares*. If any tendered Shares are not purchased or are properly withdrawn prior to the Expiration Date, such Shares will be returned to the tendering stockholder promptly after the expiration or termination of the Offer or the proper withdrawal of the Shares, without expense to the stockholder.

*U.S. Federal Backup Withholding Tax*. Under the U.S. federal backup withholding tax rules, unless an exemption applies under the applicable law and regulations, a portion of the gross proceeds payable to a tendering stockholder or other payee who is a U.S. Holder (as defined in Section 13) pursuant to the Offer must be withheld and remitted to the IRS, unless the tendering stockholder or other payee provides its taxpayer identification number (employer identification number or social security number) to the Fund (as payor) and certifies under penalties of perjury, among other things, that the number is correct. Therefore, each tendering stockholder that is a U.S. Holder should complete and sign the IRS Form W-9 included as part of the Notice of Intent to provide the information and certification necessary to avoid U.S. federal backup withholding tax, unless the stockholder or other payee otherwise establishes to the satisfaction of the Fund that the stockholder or other payee is not subject to backup withholding tax. An IRS Form W-9 currently on file with the Fund's transfer agent will not be relied upon to certify as to U.S. residency. If a U.S. Holder does not provide the Fund with the correct taxpayer identification number, the U.S. Holder may be subject to penalties imposed by the IRS. If U.S. federal backup withholding tax results in an overpayment of taxes, a refund may be obtained from the IRS in accordance with its refund procedures.

Certain "exempt recipients" (including, among others, "C corporations" and certain Non-U.S. Holders (as defined in Section 13)), are not subject to U.S. federal backup withholding tax. In order for a Non-U.S. Holder to qualify as an exempt recipient, that stockholder must submit an IRS Form W-8BEN, W-8BEN-E, W-8IMY (with any required attachments), W-8ECI, or W-8EXP, as applicable (which may be obtained on the IRS website (www.irs.gov)) signed under penalties of perjury, attesting to that stockholder's exempt status.

Information reporting to the IRS may also apply to proceeds from the Offer.

**Stockholders are urged to consult with their tax advisors regarding information reporting and possible qualifications for exemption from U.S. federal backup withholding tax and the procedure for obtaining any applicable exemption.** 

For a more complete discussion of the U.S. federal income tax consequences to tendering stockholders, see Section 13.

*Accounting Treatment*. The purchase of Shares pursuant to the Offer will result in a reduction of our stockholders' equity in an amount equal to the aggregate purchase price of the Shares we purchase and a corresponding increase in liabilities and/or reduction in total cash and cash equivalents depending on the source of funding.

*Determination of Validity; Rejection of Shares; Waiver of Defects; No Obligation to Give Notice of Defects*. All questions as to the number of Shares to be accepted and the validity, form, eligibility, including time of receipt, and acceptance for payment of any tender of Shares will be determined by AB PCIC, in its sole discretion, and such determination will be final and binding on all parties, except as finally determined in a subsequent judicial proceeding if AB PCIC's determinations are challenged by stockholders. AB PCIC reserves the absolute right to reject any or all tenders of any Shares that it determines are not in proper form or the acceptance for payment of or payment for which may, in the opinion of AB PCIC's counsel, be unlawful. AB PCIC also reserves the absolute right to waive any of the conditions of the Offer on or prior to the Expiration Date with respect to all tendered Shares in accordance with applicable law. AB PCIC also reserves the absolute right to waive any defect or irregularity in any tender with respect to any particular Shares, whether or not AB PCIC waives similar defects or irregularities in the case of any other stockholder. No tender of Shares will be deemed to have been properly made until all defects or irregularities have been cured by the tendering stockholder or waived by AB PCIC. AB PCIC will not be liable for failure to waive any condition of the Offer, or any defect or irregularity in any tender of Shares. None of AB PCIC, AB PCI or any other person will be obligated to give notice of any defects or irregularities in tenders, nor will any of them incur any liability for failure to give any such notice.

*Tendering Stockholder's Representation and Warranty; Our Acceptance Constitutes an Agreement*. It is a violation of Rule 14e-4 promulgated under the Exchange Act ("***Rule 14e-4***") for a person acting alone or in concert with others, directly or indirectly, to tender Shares for such person's own account unless, at the time of tender, such person has a "net long position" (i.e., more Shares held in long positions than in short positions) in (a) a number of Shares that is equal to or greater than the amount tendered and will deliver or cause to be delivered such Shares for the purpose of tendering to us within the period specified in the Offer or (b) other securities immediately convertible into, exercisable for or exchangeable into a number of Shares ("***Equivalent Securities***") that are equal to or greater than the number of Shares tendered and, upon the acceptance of such tender, will acquire such Shares by conversion, exchange, or exercise of such Equivalent Securities and will deliver or cause to be delivered such Shares so acquired for the purpose of tender to us within the

------

period specified in the Offer. Rule 14e-4 also provides a similar restriction applicable to the tender or guarantee of a tender on behalf of another person. A tender of Shares made pursuant to any method of delivery set forth herein will constitute the tendering stockholder's acceptance of the terms and conditions of the Offer, as well as the tendering stockholder's representation and warranty to us that (a) such stockholder has a "net long position" in a number of Shares or Equivalent Securities at least equal to the Shares being tendered within the meaning of Rule 14e-4 and (b) such tender of Shares complies with Rule 14e-4. Our acceptance for payment of Shares tendered in the Offer will constitute a binding agreement between the tendering stockholder and us upon the terms and subject to the conditions of the Offer.

**4. Withdrawal Rights** 

Shares tendered in the Offer may be withdrawn at any time prior to the Expiration Date. In addition, unless AB PCIC has already accepted your tendered Shares for payment, you may withdraw your tendered Shares at any time at or after 12:01 a.m., New York City time, on April 23, 2026. Except as otherwise provided in this Section 4, tenders of Shares pursuant to the Offer are irrevocable.

*Withdrawals*. For a withdrawal to be effective, the stockholder's financial advisor (or, if the stockholder does not have a Bernstein financial advisor, ABIS) must receive (by email, facsimile, regular mail, overnight courier or hand delivery), prior to the Expiration Date, a properly completed and duly executed Notice of Withdrawal ("***Notice of Withdrawal***") (attached as Exhibit (a)(1)(C) to the Tender Offer Statement on Schedule TO (the "***Schedule TO***")) at the financial advisor's address (or, if the stockholder does not have a Bernstein financial advisor, ABIS at the following address: 66 Hudson Boulevard East, Attn: Private Client, New York, NY 10001, fax no. (212) 407-5850). If you tendered your Shares using more than one Notice of Intent, you may withdraw Shares using either separate Notices of Withdrawal or a combined Notice of Withdrawal specifying the Shares to be withdrawn. To obtain a Notice of Withdrawal, please contact your financial advisor. If you do not have a Bernstein financial advisor, please contact ABIS at (212) 969-1000.

*Determination of Validity of Withdrawals*. All questions as to the form and validity, including the time of receipt, of any Notice of Withdrawal will be determined by us, in our sole discretion and will be final and binding on all parties, except as finally determined in a subsequent judicial proceeding if our determinations are challenged by stockholders. We reserve the absolute right to waive any defect or irregularity in the Notice of Withdrawal or method of withdrawal of Shares by any stockholder, whether or not we waive similar defects or irregularities in the case of any other stockholder. None of AB PCIC, AB PCI or any other person will be obligated to give notice of any defects or irregularities in any Notice of Withdrawal, nor will any of them incur liability for failure to give any such notice.

Withdrawals may not be rescinded, and any Shares properly withdrawn will be deemed not properly tendered for purposes of the Offer. However, properly withdrawn Shares may be re-tendered prior to the Expiration Date by following one of the procedures described in Section 3.

If we extend the Offer, are delayed in our purchase of Shares, or are unable to purchase Shares pursuant to the Offer for any reason, then, without prejudice to our rights pursuant to the Offer, your financial advisor, or if you do not have a Bernstein financial advisor, ABIS, may, subject to applicable law, retain tendered Shares on our behalf, and such Shares may not be withdrawn, except to the extent tendering stockholders are entitled to withdrawal rights as described in this Section 4.

Our reservation of the right to delay payment for Shares that we have accepted for payment is limited by Rules 13e-4(f)(5) and 14e-1(c) promulgated under the Exchange Act, which require that we must pay the consideration offered or return the Shares tendered promptly after termination or withdrawal of the Offer.

**5. Purchase of Shares and Payment of Purchase Price** 

For purposes of the Offer, we will be deemed to have accepted for payment, subject to the cutback provisions of the Offer, Shares that are properly tendered and not properly withdrawn, only when, as and if we give oral or written notice to financial advisors of our acceptance of the Shares for payment pursuant to the Offer.

For each stockholder who tenders Shares that are accepted for purchase, payment of the Purchase Price will consist of a Note entitling the stockholder to receive a cash payment in an amount per Share equal to the net asset value of such Shares, determined as of March 31, 2026. Cash payment in respect of the Note will be made to you approximately 45 days after the Expiration Date. As of December 31, 2025, the unaudited net asset value per Share was $9.48. The Fund cannot give any assurance that net asset value per Share as of March 31, 2026 will not differ, perhaps significantly, from the net asset value per Share as of December 31, 2025.

Upon the terms and subject to the conditions of the Offer, we will accept for payment and deliver the Notes for all of the Shares accepted for payment pursuant to the Offer promptly after the Expiration Date. In all cases, cash payment in respect of the Notes will be made approximately 45 days after the Expiration Date, taking into account any time necessary to determine any cutbacks, but only after timely receipt by your financial advisor, or, if you do not have a Bernstein financial advisor, ABIS, of (a) a properly completed and duly executed Notice of Intent (or an originally signed photocopy of the Notice of Intent) and (b) any other required documents.

------

In the event of cutbacks, the Fund will determine the cutback factor and deliver the Notes for those tendered Shares accepted for payment promptly after the Expiration Date. All Shares tendered and not purchased, including Shares not purchased due to cutbacks, will be credited to the account of the registered stockholder promptly after the Expiration Date or termination of the Offer.

**Under no circumstances will we pay interest on the Purchase Price, even if there is any delay in making payment. In addition, if certain events occur prior to the Expiration Date, we may not be obligated to purchase Shares pursuant to the Offer. See Section 6.** 

We will pay all stock transfer taxes, if any, payable on the transfer to us of Shares purchased pursuant to the Offer. If, however, payment of the Purchase Price is to be made to, or (in the circumstances permitted by the Offer) if unpurchased Shares are to be registered in the name of, any person other than the registered holder, the amount of all stock transfer taxes, if any (whether imposed on the registered holder or the other person), payable on account of the transfer to the person, will be deducted from the Purchase Price unless satisfactory evidence of the payment of the stock transfer taxes, or exemption from payment of the stock transfer taxes, is submitted to AB PCIC.

**6. Conditions of the Offer** 

The Offer is not conditioned upon the receipt of financing or on a minimum number of Shares being tendered. Notwithstanding any other provision of the Offer, we will not be required to accept for payment, purchase or pay for any Shares tendered, and may terminate or amend the Offer or may postpone the acceptance for payment of, or the purchase of or the payment for Shares tendered, subject to the rules promulgated under the Exchange Act, if at any time prior to the Expiration Date, any of the following events or circumstances shall have occurred (or shall have been reasonably determined by us to have occurred):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• there shall have been instituted, or there shall be pending, or we shall have received notice of any action,
suit, proceeding or application by any government or governmental, regulatory or administrative agency, authority or tribunal or by any other person, domestic, foreign or supranational, before any court, authority, agency, other tribunal or
arbitrator or arbitration panel that directly or indirectly:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• challenges or seeks to challenge, restrain, prohibit, delay or otherwise affect the making of the Offer, the
acquisition by us of some or all of the Shares pursuant to the Offer or otherwise relates in any manner to the Offer or seeks to obtain damages in respect of the Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• seeks to make the purchase of, or payment for, some or all of the Shares pursuant to the Offer illegal or may
result in a delay in our ability to accept for payment or pay for some or all of the Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• otherwise could reasonably be expected to materially adversely affect the business, properties, assets,
liabilities, capitalization, stockholders' equity, financial condition, operations, results of operations or prospects of us or any of our subsidiaries or affiliates; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• that otherwise, in our reasonable judgment, could reasonably be expected to adversely affect us or any of our
subsidiaries or affiliates or the value of our Shares;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• our acceptance for payment, purchase or payment for any Shares tendered in the Offer shall violate or conflict
with, or otherwise be contrary to, any applicable law, statute, rule, regulation, decree or order;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any action shall have been taken or any statute, rule, regulation, judgment, decree, injunction or order
(preliminary, permanent or otherwise) shall have been proposed, sought, enacted, entered, promulgated, enforced or deemed to be applicable to the Offer or us or any of our subsidiaries by any court, other tribunal, government or governmental agency
or other regulatory or administrative authority or body, domestic or foreign, which:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• indicates that any approval, waiver or other action of any such court, other tribunal, agency, authority or body
may be required in connection with the Offer or the purchase of Shares thereunder and which has not been obtained or taken, as applicable;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• is reasonably likely to make the purchase of, or payment for, some or all of the Shares pursuant to the Offer
illegal or to prohibit, restrict or delay consummation of the Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• materially impairs, in our reasonable judgment, the contemplated benefits to us of the Offer;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• seeks to impose limitations on our or our affiliates' ability to acquire or hold or to exercise full rights
of ownership, including, but not limited to, the right to vote their Shares on all matters validly presented to our stockholders; or

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• otherwise could reasonably be expected to materially adversely affect the business, properties, assets,
liabilities, capitalization, stockholders' equity, condition (financial or otherwise), operations, licenses, franchises, permits, permit applications, results of operations or prospects of us or any of our subsidiaries or affiliates;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• there shall have occurred any of the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any general suspension of trading in, or limitation on prices for, securities on any U.S. national securities
exchange or in the over—the—counter market, the declaration of a banking moratorium or any suspension of payments in respect of banks in the United States, whether or not mandatory, or any limitation, whether or not mandatory, by any
governmental, regulatory or administrative agency, authority or body on, or any event that is likely, in our reasonable judgment, to materially adversely affect, the extension of credit by banks or other lending institutions in the United States;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the commencement or escalation, on or after February 27, 2026, of war, armed hostilities or other
international or national calamity, including, but not limited to, an act of terrorism, directly or indirectly involving the United States or any other jurisdiction in which AB PCIC or any of its subsidiaries maintains an office or conducts business
(or if existing at the time of commencement of the Offer, a material worsening thereof) shall have occurred;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any change, condition, event or development or any condition, event or development involving a prospective
change, in general political, market, economic, financial or industry conditions in the United States or internationally that, in our reasonable judgment, has, or could reasonably be expected to have, a material adverse effect on the business,
properties, assets, liabilities, capitalization, stockholders' equity, condition (financial or otherwise), operations, licenses, franchises, permits, permit applications, results of operations or prospects of AB PCIC and its subsidiaries,
taken as a whole, on the value of or trading in the Shares, on our ability to consummate the Offer or on the benefits of the Offer to us;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any change, condition, event or development (including any act of nature or man-made disaster) or any condition, event or development involving a prospective change, in the business, properties, assets, liabilities, capitalization, stockholders' equity, condition (financial or
otherwise), operations, licenses, franchises, permits, permit applications, results of operations or prospects of AB PCIC or any of its subsidiaries that, in our reasonable judgment, has, or could reasonably be expected to have, a material adverse
effect on AB PCIC and its subsidiaries, taken as a whole, on the value of or trading in the Shares, on our ability to consummate the Offer or on the benefits of the Offer to us; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• in the case of any of the foregoing existing at the time of the commencement of the Offer, a material
acceleration or worsening thereof;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any decrease or increase of more than 10% in the Dow Jones Industrial Average, New York Stock Exchange Index,
NASDAQ Composite Index, the Standard and Poor's 500 Composite Index or the Wells Fargo Business Development Company Index measured from the close of trading on February 27, 2026;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• a tender or exchange offer for any or all of the outstanding Shares, or any merger, acquisition, business
combination or other similar transaction with or involving us or any of our subsidiaries, shall have been proposed, announced or made by any person or entity or shall have been publicly disclosed nor shall we have entered into a definitive agreement
or an agreement in principle with any person with respect to a merger, acquisition, business combination or other similar transaction, in each case, other than the Offer or otherwise described herein;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we shall have become aware that any entity, "group" (as that term is used in Section 13(d)(3) of
the Exchange Act) or person (a) has acquired or proposes to acquire beneficial ownership of more than 5% of the outstanding Shares, whether through the acquisition of stock, the formation of a group, the grant of any option or right (options
for and other rights to acquire Shares that are acquired or proposed to be acquired being deemed to be immediately exercisable or convertible for purposes of this clause), or otherwise (other than by virtue of consummation of the Offer or anyone who
publicly disclosed such ownership in a filing with the SEC on or before February 27, 2026), (b) who has filed a Schedule 13D or Schedule 13G with the SEC on or before February 27, 2026, has acquired or proposes to acquire, whether through
the acquisition of Shares, the formation of a group, the grant of any option or right (options for and other rights to acquire Shares that are acquired or proposed to be acquired being deemed to be immediately exercisable or convertible for purposes
of this clause), or otherwise (other than by virtue of consummation of the Offer), beneficial ownership of an additional 1% or more of the outstanding Shares or (c) shall have filed a Notification and Report Form under the Hart-Scott-Rodino
Antitrust Improvements Act of 1976, as amended, reflecting an intent to acquire us or any of our subsidiaries or any of our or any of our subsidiaries' assets or securities;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• any approval, permit, authorization, favorable review or consent or waiver of or filing with any domestic or
foreign governmental or regulatory authority, agency or body or any third party consent or notice, required to be obtained or made in connection with the Offer shall not have been obtained or made on terms and conditions satisfactory to us in our
reasonable judgment; or

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we determine, in our reasonable judgment, that the consummation of the Offer or the purchase of Shares from any
stockholder could jeopardize our qualification and taxation as a regulated investment company ("  ***RIC***") under Subchapter M of the Internal Revenue Code of 1986, as amended (the "  ***Code*** "), for U.S.
federal income tax purposes.

Each of the conditions referred to above is for our sole benefit and may be asserted or waived by us, in whole or in part, at any time and from time to time in our discretion prior to the Expiration Date. In certain circumstances, if we waive any of the conditions described above, we may be required to extend the Expiration Date.

Once the Offer has expired, all of the conditions to the Offer must have been satisfied or waived. Our failure at any time to exercise any of the foregoing rights will not be deemed a waiver of any right, and each such right will be deemed an ongoing right that may be asserted at any time and from time to time prior to the Expiration Date. Any determination by us concerning the fulfillment or non-fulfillment of the conditions described above will be final and binding on all parties, except as finally determined in a subsequent judicial proceeding if our determination is challenged by stockholders.

**7. Distributions** 

*Distributions*. The following table sets forth the distributions that have been paid and/or declared by our Board of Directors for the periods set forth below on an actual basis:

---

| | |
|:---|:---|
| **Period** | **Amount Declared**<br> **per Share** |
|  Fiscal Year ending December 31, 2025 | $0.81 |
|  Fiscal Year ending December 31, 2024 | $0.88 |

---

The following tables summarize the Fund's distributions declared during the years ended December 31, 2025 and December 31, 2024:

---

| | | | |
|:---|:---|:---|:---|
| **Date Declared** | **Record Date** | **Payment Date** | **Amount Per Share** |
|  3/27/2025 | 3/27/2025 | 4/24/2025 | $0.20 |
|  6/26/2025 | 6/26/2025 | 7/17/2025 | $0.20 |
|  9/26/2025 | 9/26/2025 | 10/23/2025 | $0.20 |
|  12/29/2025 | 12/29/2025 | 1/28/2026 | $0.21 |

---

---

| | | | |
|:---|:---|:---|:---|
| **Date Declared** | **Record Date** | **Payment Date** | **Amount Per Share** |
|  3/26/2024 | 3/26/2024 | 4/23/2024 | $0.23 |
|  6/26/2024 | 6/26/2024 | 7/22/2024 | $0.21 |
|  9/26/2024 | 9/26/2024 | 10/23/2024 | $0.23 |
|  12/27/2024 | 12/27/2024 | 1/28/2025 | $0.21 |

---

Shares purchased in the Offer will no longer be eligible for receipt of future distributions after the Expiration Date. The Fund reserves the right to increase its distributions and pay quarterly distributions in cash or in kind in the future. The Fund currently expects that distributions will continue to be declared on a quarterly basis.

The Fund currently expects to distribute a portion of its undistributed taxable income to stockholders in the form of quarterly cash distributions. Our Board of Directors intends to declare one quarterly cash distribution, in an aggregate amount of all of the net investment income of the Fund, as determined by the officers of the Fund, for the period January 1, 2026 through March 31, 2026, to stockholders of record on March 27, 2026. The payment of any quarterly cash distribution is subject to restrictions under applicable law and the sole discretion of our Board of Directors, and therefore, there can be no assurance as to the amount or timing of any such future distribution.

------

**8. Source and Amount of Funds** 

AB PCIC expects to fund any purchases of Shares pursuant to the Offer, including the related fees and expenses, from available cash and/or borrowings under its subscription financing facility (the "***HSBC Credit Facility***") evidenced by that certain Revolving Credit Agreement, dated as of June 14, 2019, by and among AB-Abbott Private Equity Investors 2019 (Delaware) Fund L.P. (together with any other borrower which becomes a party thereto, the "***HSBC Borrowers***"), AB-Abbott Private Equity Investors G.P. L.P., the banks and financial institutions from time to time party thereto as lenders, and HSBC Bank USA, National Association (the "***HSBC Administrative Agent***") (as amended, restated or otherwise modified from time to time, the "***HSBC Credit Agreement***"). The Offer is not subject to a financing contingency. If the Offer is fully subscribed, we expect the aggregate purchase price for the Shares in the Offer, together with all related fees and expenses, to be approximately $18 million.

The Fund Group Facility Sublimit (as defined in the HSBC Credit Agreement) applicable to the Fund under the HSBC Credit Facility is $42 million. The Fund Group Facility Sublimits of the HSBC Borrowers can be reallocated among the various Fund Groups (as defined in the HSBC Credit Agreement) up to an overall maximum principal amount (the "***HSBC Maximum Commitment***"), which is currently $450 million and which may be increased upon request of the HSBC Borrowers to an amount agreed upon by the HSBC Borrowers and the HSBC Administrative Agent. So long as no request for borrowing is outstanding, the HSBC Borrowers of a Fund Group may terminate the Lenders' (as defined in the HSBC Credit Agreement) commitments (the "***HSBC Commitments***") or reduce the HSBC Maximum Commitment by giving prior irrevocable written notice to the HSBC Administrative Agent.

Borrowings under the HSBC Credit Facility bear interest at a rate per annum equal to (i) with respect to SOFR Loans, Adjusted Term SOFR (as defined in the HSBC Credit Agreement) plus a spread of 3.00% per annum for the applicable Interest Period (as defined in the HSBC Credit Agreement) and (ii) with respect to Reference Rate Loans (as defined in the HSBC Credit Agreement), the Reference Rate (as defined in the HSBC Credit Agreement) in effect from day to day. The Fund will also pay an unused commitment fee of (x) with respect to any day on which the Principal Obligations (as defined in the HSBC Credit Agreement) are then-currently greater than 66% of the Maximum Commitment (as defined in the HSBC Credit Agreement), 0.35% per annum, (y) with respect to any day on which the Principal Obligations are then-currently less than or equal to 66% and greater than thirty-three percent 33% of the Maximum Commitment, 0.50% per annum and (z) with respect to any day on which the Principal Obligations are then-currently less than or equal to 33% of the Maximum Commitment, 1.00% per annum.

The HSBC Credit Facility will mature on December 7, 2026, subject to earlier termination with respect to any applicable Fund Group following an Event of Default (as defined in the HSBC Credit Agreement), termination by the applicable HSBC Borrowers or expiration of the ability to call capital commitments (as defined in the HSBC Credit Agreement).

Subject to certain terms and conditions, the Fund's obligations under the HSBC Credit Facility are secured by a first priority, exclusive, perfected security interest and lien in and on all of the Fund's right, title and interest, in, to and under (i) all of the Fund's rights, titles, interests and privileges in and to the Capital Commitments, and the Capital Contributions (as defined in the HSBC Credit Agreement) made by the Investors (as defined in the HSBC Credit Agreement), and all other rights, titles, interests, powers and privileges related to, appurtenant to or arising out of the Capital Commitments; (ii) all of the Fund's rights, titles, interests, remedies, and privileges under its Constituent Documents (as defined in the HSBC Credit Agreement) (a) to issue and enforce Capital Calls (as defined in the HSBC Credit Agreement) and Pending Capital Calls (as defined in the HSBC Credit Agreement), (b) to receive and enforce Capital Contributions and (c) relating to Capital Calls, Pending Capital Calls, Capital Commitments or Capital Contributions; and (iii) all proceeds of any and all of the foregoing.

The HSBC Credit Facility contains customary covenants and events of default (with customary cure and notice provisions). As of February 27, 2026, the Fund is in compliance with these covenants. The terms of the HSBC Credit Facility are applicable severally and not jointly to the various Fund Groups, including for the avoidance of doubt, the Fund, such that the representations, warranties, covenants, obligations and indemnities of each Fund Group are applicable only against that Fund Group, and the assets of the Fund that are subject to the HSBC Credit Facility are not cross-collateralized with the security interests of the other HSBC Borrowers under the HSBC Credit Facility.

The Fund currently does not have any plans or arrangements to finance or repay the borrowings under the HSBC Credit Facility.

**9. Certain Information Concerning the Fund** 

We are an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company ("***BDC***") under the 1940 Act. We have elected to be treated for U.S. federal income tax purposes, and intend to qualify annually, as a RIC under Subchapter M of the Code. We are managed by AB PCI, which is as an investment adviser with the SEC. AB PCI oversees the management of our activities and is responsible for making investment decisions for our portfolio.

------

Our investment objective is to generate current income and prioritize capital preservation through a portfolio that primarily invests in directly-sourced, privately-negotiated, secured, middle market loans. We also have the ability, as granted through an exemptive order granted by the SEC, to co-invest in privately negotiated transactions alongside other investment funds managed by or affiliated with AB PCI. We will invest at least 80% of our assets in debt instruments. We intend to invest in middle-market businesses based in the United States, which we generally define as having enterprise values between $50 million and $500 million. However, from time to time, we may invest in larger or smaller companies.

Our principal office is located at 405 Colorado Street, Suite 1500, Austin, TX 78701 and our telephone number is (512) 721-2900.

As of September 30, 2025, our investment portfolio, with a total fair value of approximately $1.80 billion consisted of interests in 214 portfolio companies. As of September 30, 2024, our investment portfolio, with a total fair value of approximately $1.53 billion, consisted of interests in 201 portfolio companies.

*Available Information*. We are subject to the informational filing requirements of the Exchange Act, and, accordingly, are obligated to file reports, statements and other information with the SEC relating to our business, financial condition and other matters. Information, as of particular dates, concerning our directors and executive officers, their remuneration, incentive compensation granted to them, the principal holders of our securities and any material interest of these persons in transactions with us is required to be disclosed in proxy statements distributed to our stockholders and filed with the SEC. We also have filed the Schedule TO with the SEC that includes additional information relating to the Offer.

These reports, statements and other information can be inspected and copied at the public reference facilities maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. Copies of this material may also be obtained by mail, upon payment of the SEC's customary charges, from the Public Reference Section of the SEC at 100 F Street, N.E., Room 1580, Washington, D.C. 20549. The SEC also maintains a website on the Internet at http://www.sec.gov that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC. You may access the Fund's publicly filed documents at this site, including the Schedule TO and the documents incorporated therein by reference. You may obtain information about the Public Reference Room by calling the SEC for more information at 1-800-SEC-0330. You may also go to the Fund's investor portal to access the Schedule TO and related documents.

*Incorporation by Reference*. The rules promulgated by the SEC allow us to "incorporate by reference" information into this Offer to Purchase, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The following documents that have been previously filed with the SEC contain important information about us and we incorporate them by reference:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Annual Report on Form 10-K for the fiscal year ended December 31,
2024, as filed on March 31, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Quarterly Reports on Form 10-Q for the quarters ended March 31,
2025, June 30, 2025 and September 30, 2025, as filed on May 15, 2025, August 14, 2025 and November 12, 2025, respectively; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Current Reports on Form 8-K (excluding any information furnished therein)
as filed on January 27, 2025, February 18, 2025; February 21, 2025; March 12, 2025; March 27, 2025, May 14, 2025, July 28, 2025, September 11, 2025, September 19, 2025, September 24, 2025;
September 29, 2025; October 27, 2025; October 30, 2025; November 13, 2025; November 20, 2025; December 12, 2025; December 23, 2025; February 10, 2026; February 12, 2026; February 20, 2026 and
February 25, 2026.

Any statement contained in any document incorporated by reference in this Offer to Purchase shall be deemed to be modified or superseded to the extent that an inconsistent statement is made in this Offer to Purchase. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Offer to Purchase.

------

You may request a copy of these filings, at no cost, by writing or telephoning the Fund at its address and telephone number set forth below:

**AB Private Credit Investors Corporation** 

**Attn: Private Client** 

**66 Hudson Boulevard East,** 

**New York, NY 10001** 

**Call Toll Free: (212) 969-1000** 

**10. Interests of Directors, Executive Officers and Affiliates; Transactions and Arrangements Concerning the Shares** 

*Shares Outstanding*. As of December 31, 2025, there were 77,076,615 issued and outstanding Shares, and as of February 27, 2026, there were 77,076,221 issued and outstanding Shares. If the Offer is fully subscribed, we could purchase 1,861,300.28 Shares, which would represent 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025.

*Interests of Directors and Executive Officers*. As of February 27, 2026, none of our executive officers owned any Shares. As of February 27, 2026, our directors and executive officers as a group (7 persons) beneficially owned an aggregate of 50,710.252 Shares. None of our directors or executive officers intends to tender any Shares in the Offer. However, our directors and executive officers may in the future, subject to applicable law and applicable policies and practices of the Fund, sell their Shares from time to time in open market transactions at prices that may be more or less favorable than the Purchase Price to be paid to our stockholders pursuant to the Offer.

The following tables set forth the aggregate number of Shares that were beneficially owned (as determined under Rule 13d-3 promulgated under the Exchange Act) by each of our current directors and executive officers, and by all directors and executive officers as a group, as of February 27, 2026. No person owned (to our knowledge and based on the most current Schedule 13Ds and 13Gs filed with the SEC for each such person) more than 5% of the outstanding Shares as of February 27, 2026. For purposes of these tables, and in accordance with the rules promulgated by the SEC, Shares are considered "beneficially owned" if the person directly or indirectly has sole or shared power to vote or direct the voting of the securities or has sole or shared power to divest of or direct the divestment of the securities. A person is also considered to beneficially own Shares that he or she has the right to acquire within 60 days after February 27, 2026, in accordance with Rule 13d-3 promulgated under the Exchange Act. Except as indicated, each holder has sole voting and dispositive power over the listed Shares.

The business address of each of our directors and executive officers is c/o AB Private Credit Investors Corporation, 405 Colorado Street, Suite 1500, Austin, TX 78701.

---

| | | |
|:---|:---|:---|
| **Name of Beneficial Owner** | **Number of**<br>**Shares** | **Total Beneficial**<br>**Ownership (%)** |
|  **Interested Directors** |  |  |
| J. Brent Humphries |  | 0 |
|  Matthew Bass |  | 0 |
|  **Independent Directors** |  |  |
|  John G. Jordan | 24754.684 | \* |
|  Richard S. Pontin |  | 0 |
|  Terry Sebastian | 25955.568 | 0 |
|  **Executive Officers** |  |  |
|  Jennifer Friedland |  | 0 |
|  Wesley Raper |  | 0 |
|  **All directors and executive officers as a group (7 persons)** | 50710.252 | \* |

---

\* Represents less than 1% 

*Distribution Reinvestment Plan*. The Fund continues to maintain its existing amended and restated distribution reinvestment plan, which first became effective on November 11, 2021.

*Recent Securities Transactions*. Based on our records and on information provided to us by our directors, executive officers, affiliates and subsidiaries, other than John G. Jordan's and Terry Sebastian's acquisitions of Shares as reported on Form 4, and Mr. Jordan's and Mr. Sebastian's receipt of Shares consistent with the terms of the Fund's Distribution Reinvestment Plan, none of the Fund or any of our directors, executive officers, affiliates or subsidiaries have effected any other transactions involving our Shares during the 60 days prior to February 27, 2026.

------

*Other Interests*. Except as otherwise described or incorporated by reference in this Offer to Purchase, the Schedule TO or the Fund's Annual Report on Form 10-K for the year ended December 31, 2020, which descriptions are incorporated herein by reference, none of the Fund nor, to the best of the Fund's knowledge, any of its affiliates, directors or executive officers, is a party to any contract, arrangement, understanding or relationship with any other person relating, directly or indirectly, to the Offer or with respect to any securities of the Fund, including, but not limited to, any contract, arrangement, understanding or relationship concerning the transfer or the voting of securities, joint ventures, loan or option arrangements, puts or calls, guaranties of loans, guaranties against loss or the giving or withholding of proxies, consents or authorizations.

**11. Registration under the Exchange Act** 

The class of Shares is registered under the Exchange Act, which requires, among other things, that we furnish certain information to our stockholders and the SEC and comply with the SEC's proxy rules in connection with meetings of our stockholders. We believe that our purchase of Shares pursuant to the Offer pursuant to the terms of the Offer will not result in the class of Shares being deregistered under the Exchange Act.

**12. Certain Legal Matters; Regulatory Approvals** 

We are not aware of any other license or regulatory permit that is material to our business that might be adversely affected by our acquisition of Shares as contemplated pursuant to the Offer, nor are we aware of any approval or other action by any government or governmental, administrative or regulatory authority, agency or body, domestic, foreign or supranational, that would be required for our acquisition or ownership of Shares as contemplated by the Offer. Should any such approval or other action or notice filings be required, we presently contemplate that we will seek that approval or other action and make or cause to be made such notice filings. We cannot predict whether we will be required to delay the acceptance for payment of or payment for Shares tendered in the Offer pending the outcome of any such approval or other action. There can be no assurance that any such approval or other action, if needed, would be obtained or would be obtained without substantial cost or conditions or that the failure to obtain the approval or other action might not result in adverse consequences to our business and financial condition. Our obligations pursuant to the Offer to accept for payment and pay for Shares are subject to the satisfaction of certain conditions. See Section 6.

**13. Material U.S. Federal Income Tax Consequences** 

The following is a summary of the material U.S. federal income tax consequences of the Offer to U.S. Holders and Non-U.S. Holders (each as defined below), in each case, whose Shares are tendered and accepted for payment pursuant to the Offer. This summary is based upon the Code, U.S. Treasury Regulations promulgated under the Code, published rulings, administrative pronouncements and judicial decisions, any changes to which could affect the tax consequences described in this Offer (possibly on a retroactive basis). This summary assumes that Shares held by stockholders as capital assets within the meaning of section 1221 of the Code (generally, property held for investment). This summary will not be updated for any changes in law and it does not address all of the tax consequences that may be relevant to particular stockholders in light of their particular circumstances, or to stockholders subject to special rules, including, without limitation, pass-through entities (including arrangements and entities treated as partnerships, "grantor trusts" and S corporations for U.S. federal income tax purposes) and investors in such entities, certain financial institutions, brokers, dealers or traders in securities or commodities, insurance companies, U.S. expatriates, mutual funds, real estate investment trusts, BDCs, cooperatives, trusts and estates, persons who mark-to-market our Shares, tax-exempt organizations, persons who are subject to the alternative minimum tax, persons who hold Shares as a position in a "straddle" or as part of a "hedging" or "conversion" transaction or other integrated investment, stockholders that have a functional currency other than the U.S. dollar, or persons who acquired their Shares upon the exercise of stock options or otherwise as compensation. This summary also does not address any state, local, non-U.S. or other tax consequences of participating in the Offer. This summary assumes that AB PCIC is and will remain a RIC for U.S. federal income tax purposes for its taxable year which includes each exchange of Shares pursuant to the Offer.

**You are urged to consult your tax advisor as to the particular consequences of your participation in the Offer.** 

For purposes of this discussion, a "U.S. Holder" is a beneficial holder of Shares that, for U.S. federal income tax purposes, is (a) a citizen or individual resident of the United States, (b) a corporation, or other entity treated as a corporation for U.S. federal income tax purposes, that is created or organized in or under the laws of the United States or any State or the District of Columbia, (c) an estate, the income of which is subject to U.S. federal income taxation regardless of its source or (d) a trust if (x) a U.S. court is able to exercise primary supervision over its administration and one or more U.S. persons, within the meaning of section 7701(a)(30) of the Code, have authority to control all of its substantial decisions, or (y) it has a valid election in place to be treated as a U.S. person.

A "Non-U.S. Holder" is a beneficial holder of Shares that is not a "pass-through entity" (including a partnership) for U.S. federal income tax purposes and that also is not a U.S. Holder.

------

*U.S. Holders*. An exchange of Shares by a U.S. Holder for cash payment in respect of the Note pursuant to the Offer will be a taxable transaction for U.S. federal income tax purposes. The U.S. federal income tax consequences to a U.S. Holder may vary depending upon the U.S. Holder's particular facts and circumstances. If, as described below, an exchange of Shares by a U.S. Holder for cash payment in respect of the Note pursuant to the Offer is treated as a sale or exchange of such Shares for U.S. federal income tax purposes, the U.S. Holder will generally recognize capital gain or loss in an amount equal to the difference between the amount of cash received in respect of the Note pursuant to the Offer and the U.S. Holder's adjusted tax basis in the Shares purchased by AB PCIC. Such gain or loss generally will be long-term capital gain or loss if the U.S. Holder's holding period for the Shares at the time of the exchange exceeds one year. The maximum tax rate applicable to capital gains recognized by individuals and other non-corporate taxpayers is generally (i) the same as the applicable ordinary income rate for capital assets held for one year or less, or (ii) 15% or 20% (depending on whether the taxpayer's income exceeds certain threshold amounts) for capital assets held for more than one year. Specific limitations may apply to the deductibility of capital losses by a U.S. Holder. In addition, any loss upon an exchange of Shares by a U.S. Holder for the cash payment in respect of the Note pursuant to the Offer who has held the Shares for six months or less, after applying holding period rules, generally will be treated as a long-term capital loss to the extent of distributions received from AB PCIC that were required to be treated by the U.S. Holder as long-term capital gain.

An exchange of Shares by a U.S. Holder for cash payment in respect of the Note pursuant to the Offer will be treated as a sale or exchange for U.S. federal income tax purposes if the exchange (a) is "not essentially equivalent to a dividend" with respect to the U.S. Holder, (b) is a "substantially disproportionate" redemption with respect to the U.S. Holder or (c) is a "complete redemption" of all Shares owned by the U.S. Holder. In determining whether any of these tests has been met, a U.S. Holder generally must take into account not only Shares it actually owns, but also Shares it constructively owns as determined under section 318 of the Code (including, without limitation, Shares that may be acquired through options that it owns or Shares held by certain members of the U.S. Holder's family).

An exchange of Shares for cash by a U.S. Holder for cash payment in respect of the Note pursuant to the Offer will be treated as "not essentially equivalent to a dividend" if it results in a "meaningful reduction" in the U.S. Holder's stock interest in AB PCIC. Whether such a meaningful reduction of the U.S. Holder's stock interest in AB PCIC results will depend on the U.S. Holder's particular facts and circumstances. If, as a result of an exchange of Shares for cash payment in respect of the Note pursuant to the Offer, a U.S. Holder whose relative stock interest in AB PCIC is minimal (e.g., less than 1%) and who exercises no control over the corporate affairs of AB PCIC suffers any reduction in its proportionate stock interest in AB PCIC (including any Shares constructively owned), the U.S. Holder generally should be regarded as having suffered a meaningful reduction in its stock interest in AB PCIC. U.S. Holders should note, however, that because other holders may exchange a greater percentage of their Shares pursuant to the Offer than a particular U.S. Holder, the interest in AB PCIC of a U.S. Holder may increase immediately following the Offer even if both that U.S. Holder exchanges Shares pursuant to the Offer and neither it nor any person whose ownership of Shares is attributed to such U.S. Holder pursuant to the constructive ownership rules described above acquires any other Shares.

Satisfaction of the "substantially disproportionate" test or "complete redemption" test is dependent upon satisfaction of the objective tests respectively set forth in section 302(b)(2) and section 302(b)(3) of the Code. An exchange of Shares by a U.S. Holder for cash payment in respect of the Note pursuant to the Offer will satisfy the "substantially disproportionate" test if (a) the percentage of the outstanding voting shares of AB PCIC actually and constructively owned by the U.S. Holder immediately following the exchange is less than 80% of the percentage of the outstanding voting shares of AB PCIC actually and constructively owned by the U.S. Holder immediately before the exchange, (b) the percentage of the outstanding Shares actually and constructively owned by the U.S. Holder immediately following the exchange is less than 80% of the percentage of the outstanding Shares actually and constructively owned by the U.S. Holder immediately before the exchange, and (c) immediately following the exchange, the U.S. Holder actually and constructively owns less than 50% of the total combined voting power of all classes of voting shares of AB PCIC.

An exchange of Shares by a U.S. Holder for cash payment in respect of the Note pursuant to the Offer generally will result in a "complete redemption" if either (a) all of the Shares actually and constructively owned by the U.S. Holder are exchanged for cash payment in respect of the Note pursuant to the Offer or (b) all of the Shares actually owned by the U.S. Holder are exchanged for cash payment in respect of the Note pursuant to the Offer, the U.S. Holder constructively holds Shares solely as a result of the constructive ownership rules relating "family attribution," the U.S. Holder timely and properly waives the attribution of those Shares constructively owned by the U.S. Holder in accordance with the procedures described in section 302(c)(2) of the Code and the Treasury Regulations promulgated thereunder, and complies with certain other requirements relating to share ownership in AB PCIC. U.S. Holders desiring to waive such constructive ownership of Shares should consult their tax advisors about the applicability of section 302(c)(2) of the Code in their particular circumstances.

U.S. Holders should be aware that an acquisition or disposition of Shares (including by persons whose ownership of outstanding Shares is attributed to a U.S. Holder pursuant to the constructive ownership rules described above) as part of a plan that includes the U.S. Holder's tender of Shares pursuant to the Offer should be taken into account in determining whether any of the foregoing tests is satisfied. U.S. Holders are urged to consult their tax advisors with regard to whether acquisitions from or sales to third parties and a tender may be so integrated. U.S. Holders should also be aware that their ability to satisfy any of the foregoing tests may be affected by cutbacks pursuant to the Offer. **Therefore, the U.S. Holder can be given no assurance, even if the U.S. Holder tenders all of the U.S. Holder's Shares, that we will purchase a sufficient number of such Shares to permit the stockholder to satisfy any of the foregoing tests. The application of section 302 of the Code is complex. U.S. Holders intending to rely on any of the tests described above should consult their tax advisors to determine the application of these rules in their particular circumstances**.

------

If a U.S. Holder's exchange of Shares for cash payment in respect of the Note pursuant to the Offer does not constitute a sale or exchange for U.S. federal income tax purposes, the receipt of cash payment in respect of the Note by such U.S. Holder pursuant to the Offer will be treated as a distribution by AB PCIC to such U.S. Holder, and the U.S. Holder's adjusted tax basis in the Shares exchanged generally will be added to any Shares retained by the U.S. Holder. If the exchanging U.S. Holder owns no other Shares, under certain circumstances, such basis may be transferred to a related person, or it may be lost entirely. The distribution will be treated as a dividend to the extent of AB PCIC's current and accumulated earnings and profits, as determined under U.S. federal income tax principles. To the extent that the amount of the distribution exceeds AB PCIC's current and accumulated earnings and profits, the excess first will be treated as a return of capital that will reduce the U.S. Holder's adjusted tax basis in its Shares, and any remaining portion will be taxable as capital gain. Any distributions that are designated as capital gains dividends will be taxed to U.S. Holders as long-term capital gains, to the extent that they do not exceed the actual net capital gain of AB PCIC for the taxable year; without regard to the period for which the U.S. Holder has held its Shares. Any such capital gain will be long-term capital gain if the U.S. Holder's holding period for the Shares at the time of the exchange exceeds one year. In light of our investment strategies, dividend income received by a U.S. Holder will generally be taxed at ordinary income rates of up to 37%. Dividend income from us will generally not be eligible for the preferential tax rate on "qualified dividend income" received by U.S. Holders taxed at individual rates from domestic C corporations and certain qualified foreign corporations, except to the extent such dividend income is attributable to dividends received by us from certain corporations. Additionally, dividends received by U.S. Holders who are corporations will not qualify for the dividends received deduction generally available to corporations. In addition, if a U.S. Holder's exchange of Shares for cash payment in respect of the Note pursuant to the Offer is treated as a dividend to a tendering stockholder, the IRS may take the position that a constructive distribution under section 305(c) of the Code may result to a stockholder whose proportionate interest in the earnings and assets of AB PCIC has been increased by such tender. Stockholders are urged to consult their own tax advisors regarding the possibility of deemed distributions resulting from the sale of Shares pursuant to the Offer.

Contemporaneous acquisitions or dispositions of Shares by a U.S. Holder or related parties or entities may be deemed to be part of a single integrated transaction and may be taken into account in determining the tax treatment of the Offer to a U.S. Holder. In addition, we cannot predict whether or the extent to which the Offer will be over-subscribed. If the Offer is over-subscribed, cutback of tenders pursuant to the Offer will cause us to accept fewer Shares than are tendered. Therefore, a U.S. Holder can be given no assurance that a sufficient number of such U.S. Holder's Shares will be purchased pursuant to the Offer to ensure that such purchase will be treated as a sale or exchange, rather than as a distribution, for U.S. federal income tax purposes pursuant to the rules discussed above.

An additional 3.8% Medicare tax is imposed on certain net investment income (including ordinary dividends and capital gain distributions received from the Fund and net gains from redemptions or other taxable dispositions of Shares) of U.S. individuals, estates and trusts to the extent that such person's "modified adjusted gross income" (in the case of an individual) or "adjusted gross income" (in the case of an estate or trust) exceed certain threshold amounts. Stockholders should consult their tax advisors regarding the applicability of the Medicare tax to their sale of Shares pursuant to the Offer.

The Fund may be required to withhold a portion of the gross proceeds paid to a U.S. Holder or other payee pursuant to the Offer as backup withholding unless the U.S. Holder has completed and submitted to the Fund an IRS Form W-9 providing the U.S. Holder's employer identification number or social security number, as applicable, and certifying under penalties of perjury that: (a) such number is correct; (b) either (x) the U.S. Holder is exempt from backup withholding, (y) the U.S. Holder has not been notified by the IRS that the U.S. Holder is subject to backup withholding as a result of an underreporting of interest or dividends or (z) the IRS has notified the U.S. Holder that the U.S. Holder is no longer subject to backup withholding; or (c) an exception applies under applicable law. The applicable rate for backup withholding is currently 24%. Even though the Fund may have received a completed IRS Form W-9 from a U.S. Holder, the Fund may nevertheless be required to backup withhold if it receives a notice from the IRS to that effect.

*Non-U.S. Holders*. As discussed above, an exchange of Shares for cash payment in respect of the Note pursuant to the Offer by a Non-U.S. Holder will either be treated as a sale or exchange (if the tests described above with respect to U.S. Holders are satisfied) or, alternatively, a distribution for U.S. federal income tax purposes. Any payments to a Non-U.S. Holder that are treated as dividends for U.S. federal income tax purposes under the rules set forth above, will generally be subject to U.S. withholding tax at the rate of 30% (unless a reduced rate applies under an applicable tax treaty). A tendering Non-U.S. Holder who realizes a capital gain on a tender of Shares will generally not be subject to U.S. federal income tax on such gain, unless the stockholder is an individual who is physically present in the United States for 183 days or more and certain other conditions exist. Such persons are advised to consult their own tax advisor. Special rules may apply in the case of Non-U.S. Holders (a) that are engaged in a U.S. trade or business, (b) that are former citizens or residents of the U.S. or (c) that have a special status for U.S. federal tax purposes, such as "controlled foreign corporations," corporations that accumulate earnings to avoid U.S. federal income tax, and certain foreign charitable organizations. Such persons are advised to consult their own tax advisor.

------

The Fund generally will withhold an amount of U.S. federal income tax equal to 30% of the gross payments payable to a Non-U.S. Holder that are treated as a dividend, unless the Non-U.S. Holder timely delivers to their financial advisor, or if they do not have a Bernstein financial advisor, ABIS, a properly completed and executed IRS Form W-8BEN, W-8BEN-E, W-8IMY (with any required attachments), W-8ECI, or W-8EXP, as applicable, evidencing that such withholding is not required or a reduced rate of withholding (for instance, pursuant to an applicable income tax treaty) is applicable. If a Non-U.S. Holder holds its Shares through a broker or other intermediary, the withholding tax described above may be withheld by such intermediary. However, amounts withheld may be refundable if, for instance, it is subsequently determined that the distribution was, in fact, in excess of our current and accumulated earnings and profits, or that the exchange of Shares by such Non-U.S. Holder was treated as an exchange of such Shares for U.S. federal income tax purposes (and not as a distribution for U.S. federal income tax purposes), provided that certain conditions are met. If the amounts are deemed refundable, the Non-U.S. Holder will generally be required to file a U.S. tax return to claim the refund.

A foreign financial institution or non-financial foreign entity that tenders Shares which are accepted for purchase pursuant to the Offer will generally be subject to withholding tax imposed under Sections 1471 to 1474 of the Code (such Sections commonly referred to as the Foreign Account Tax Compliance Act, or "***FATCA***") and applicable U.S. Treasury regulations promulgated thereunder at a rate of 30% of the gross proceeds payable to such foreign financial institution or non-financial foreign entity unless such foreign financial institution or non-financial foreign entity provides to the applicable withholding agent an applicable IRS Form W-8 demonstrating that FATCA withholding is not required. If the applicable withholding agent withholds tax under FATCA, it will not also withhold the 30% U.S. federal income tax described previously. The U.S. Treasury Department has released proposed U.S. Treasury regulations which, if finalized in their present form, would eliminate the application of withholding imposed under FATCA with respect to payments of gross proceeds. Pursuant to these proposed U.S. Treasury regulations, the Fund and any other applicable withholding agent may (but is not required to) rely on this proposed change to FATCA withholding until final regulations are issued or until such proposed U.S. Treasury regulations are rescinded. Non-U.S. Holders are urged to consult their own tax advisors to determine the effect, if any, of FATCA on their participation in the Offer.

**The preceding discussion is not tax advice. You are urged to consult your tax advisor to determine the particular tax consequences to you of the Offer, including the applicability and effect of U.S. federal, state, local, non-U.S. and other tax laws.** 

**14. Extension of the Offer; Termination; Amendment** 

Subject to applicable law and any rules and regulations promulgated by the SEC, we expressly reserve the right, in our sole discretion, at any time and from time to time, and regardless of whether any of the events set forth in Section 6 shall have occurred or shall be deemed by us to have occurred, to extend the period of time the Offer is open and delay acceptance for payment of, and payment for, any Shares by giving oral or written notice of such extension to financial advisors and making a public announcement of such extension. We also expressly reserve the right, in our sole discretion, to terminate the Offer and reject for payment, and not pay for, any Shares not theretofore accepted for payment or paid for or, subject to applicable law, postpone payment for Shares, if any of the conditions specified in Section 6 are not satisfied or waived prior to the Expiration Date, by giving oral or written notice of such termination or postponement to the financial advisors and making a public announcement of such termination or postponement. Our reservation of the right to delay payment for Shares that we have accepted for payment is limited by Rules 13e-4(f)(5) and 14e-1(c) promulgated under the Exchange Act, which require that we must pay the consideration offered or return the Shares tendered promptly after termination or withdrawal of the Offer.

Subject to compliance with applicable law, we further reserve the right, in our sole discretion, to amend the Offer in any respect (including, without limitation, by decreasing or increasing the consideration offered pursuant to the Offer to stockholders or by decreasing or increasing the aggregate value of Shares being sought in the Offer). Amendments to the Offer may be made at any time and from time to time by public announcement of such amendments. In the case of an extension, the notice of the amendment must be issued no later than 9:00 a.m., New York City time, on the next business day after the last previously scheduled or announced Expiration Date. Any public announcement made pursuant to the Offer will be disseminated promptly to stockholders in a manner reasonably designed to inform stockholders of such change. Without limiting the manner in which we may choose to make a public announcement, except as required by applicable law, we shall have no obligation to publish, advertise or otherwise disseminate any such public announcement other than by issuing a press release.

If we materially change the terms of the Offer or the information concerning the Offer, or if we waive a material condition of the Offer, we will extend the Offer to the extent required by Rules 13e-4(d)(2), 13e-4(e)(3) and 13e-4(f)(1) promulgated under the Exchange Act. These rules and certain related releases and interpretations of the SEC provide that the minimum period during which a tender offer must remain open following material changes in the terms of the tender offer or information concerning the tender offer (other than a change in price or a change in percentage of securities sought) will depend on the facts and circumstances, including the relative materiality of such terms or information. If:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• we increase or decrease the price to be paid for Shares; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• the Offer is scheduled to expire at any time earlier than the expiration of a period ending on the tenth business
day from, and including, the date that notice of such an increase or decrease is first published, sent or given to stockholders in the manner specified in this Section 14, then the Offer will be extended until the expiration of the period of 10
business days. For purposes of the Offer, a "business day" means any day other than a Saturday, Sunday or federal holiday and consists of the time period from 12:01 a.m. through 12:00 Midnight, New York City time.

------

In accordance with the rules promulgated by the SEC, we may increase the number of Shares accepted for payment in the Offer by up to 2% of the outstanding Shares without amending or extending the Offer.

**15. Fees and Expenses** 

We will not pay any fees or commissions to brokers, dealers or other persons for soliciting tenders of Shares pursuant to the Offer. No broker, dealer, commercial bank or trust company has been authorized to act as our agent, or the agent of AB PCI, for purposes of the Offer. We will pay or cause to be paid all stock transfer taxes, if any, on our purchase of Shares, except as otherwise provided in Section 5.

**16. Miscellaneous** 

We are not aware of any jurisdiction where the making of the Offer is prohibited by any administrative or judicial action pursuant to any valid state statute. If we become aware of any valid state statute prohibiting the making of the Offer or the acceptance of the Shares, we will make a good faith effort to comply with that state statute or seek to have such statute declared inapplicable to the Offer. If, after a good faith effort, we cannot comply with the state statute, we will not make the Offer to, nor will we accept tenders from or on behalf of, the holders of Shares in that state. In any jurisdiction where the securities, blue sky or other laws require the Offer to be made by a licensed broker or dealer, the Offer shall be deemed to be made by one or more registered brokers or dealers licensed under the laws of that jurisdiction.

Pursuant to Rule 13e-4(c)(2) promulgated under the Exchange Act, we have filed with the SEC the Schedule TO, which contains additional information relating to the Offer. The Schedule TO, including the exhibits and any amendments and supplements thereto, may be examined, and copies may be obtained, at the same places and in the same manner as is set forth in Section 9 with respect to information concerning AB PCIC.

------

**We have not authorized any person to make any recommendation on our behalf as to whether you should tender or refrain from tendering your Shares in the Offer. You should rely only on the information in or incorporated by reference in this Offer to Purchase and the Notice of Intent or in the other documents to which we have referred you. Our delivery of this Offer to Purchase shall not under any circumstances create any implication that the information in this Offer to Purchase is correct as of any time other than the date of this Offer to Purchase or that there have been no changes in the information in or incorporated by reference herein or in the affairs of AB PCIC or any of its subsidiaries since the date hereof. We have not authorized anyone to provide you with information in connection with the Offer other than the information in this Offer to Purchase or the Notice of Intent. If anyone makes any recommendation or gives any information, you must not rely upon that recommendation or information as having been authorized by us, any member of our Board of Directors, AB PCI or any of our or their respective affiliates.** 

AB Private Credit Investors Corporation

February 27, 2026

## Ex-99.(A)(1)(B)

**Exhibit (a)(1)(B)** 

**NOTICE OF INTENT TO TENDER** 

**REGARDING** 

**SHARES** 

**OF** 

**AB PRIVATE CREDIT INVESTORS CORPORATION** 

**Tendered Pursuant to the Offer to Purchase Dated February 27, 2026** 

**THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT, AND THIS NOTICE OF INTENT TO TENDER MUST BE RECEIVED BY, 5:00 P.M. EASTERN TIME ON MARCH 31, 2026 (THE "EXPIRATION DATE"), UNLESS THE OFFER IS EXTENDED.** 

**Complete this Notice of Intent to Tender and return or deliver it to your Bernstein advisor.** 

**If you do not have a Bernstein advisor, you may return it to:** 

**66 Hudson Boulevard East, Attn: Private Client,** 

**New York, New York, 10001; or fax it to (212) 407-5850.** 

**For additional information, call your Bernstein advisor.** 

**You may also direct questions to the main office of Bernstein at (212) 486-5800.** 

**AB Private Credit Investors Corporation** 

The undersigned hereby tenders to AB Private Credit Investors Corporation, an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended ("AB PCIC" or the "Fund"), shares of the Fund's common stock, par value $0.01 per shares (the "Shares"), held by the undersigned, described and specified below, on the terms and conditions set out in the Offer to Purchase, dated February 27, 2026 (the "Offer to Purchase"), receipt of which is hereby acknowledged, and in this Notice of Intent to Tender. THE OFFER AND THIS NOTICE OF INTENT TO TENDER ARE SUBJECT TO ALL THE TERMS AND CONDITIONS SET OUT IN THE OFFER TO PURCHASE INCLUDING, BUT NOT LIMITED TO, THE ABSOLUTE RIGHT OF THE FUND OR ITS AGENTS TO REJECT ANY AND ALL TENDERS DETERMINED BY IT, IN ITS SOLE DISCRETION, NOT TO BE IN THE APPROPRIATE FORM.

The undersigned hereby sells to the Fund the Shares tendered pursuant to this Notice of Intent to Tender. The undersigned warrants that it has full authority to sell the Shares tendered hereby and that the Fund will acquire good title to the Shares, free and clear of all liens, charges, encumbrances, conditional sales agreements or other obligations relating to this sale, and not subject to any adverse claim, when and to the extent the Shares are purchased by the Fund. Upon request, the undersigned will execute and deliver any additional documents necessary to complete the sale in accordance with the terms set out in the Offer to Purchase.

The undersigned recognizes that under certain circumstances set out in the Offer to Purchase, the Fund may not be required to purchase the Shares tendered hereby.

Until cash payment has been made, a non-interest bearing, non-transferable promissory note for the purchase price will be held in an account for the undersigned with AllianceBernstein Investor Services, Inc., the Company's transfer agent and agent designated for this purpose. A copy may be requested by calling your Bernstein advisor and, upon request, will be provided to the undersigned at the email address on record with the Fund, or by mail at the address of the undersigned as maintained in the Fund's records. Subsequently, cash payment of the purchase price for the Shares tendered by the undersigned will be made as instructed in Part 3 of this Notice of Intent to Tender. The undersigned understands that the purchase price will be based on the unaudited net asset value per Share as of March 31, 2026. All authority conferred or agreed to be conferred in this Notice of Intent to Tender will survive the death or incapacity of the undersigned and the obligation of the undersigned hereunder will be binding on the heirs, personal representatives, successors and assigns of the undersigned. Except as stated in the Offer to Purchase, this tender is irrevocable.

------

**PLEASE FAX, MAIL OR EMAIL THIS NOTICE OF INTENT TO TENDER TO YOUR BERNSTEIN ADVISOR NO LATER THAN 5:00 P.M. EASTERN TIME ON THE EXPIRATION DATE. IF YOU DO NOT HAVE A BERNSTEIN ADVISOR, THIS NOTICE OF INTENT TO TENDER MUST BE RECEIVED IN GOOD ORDER, NO LATER THAN 5:00 P.M. EASTERN TIME ON THE EXPIRATION DATE, BY THE COMPANY'S TRANSFER AGENT, ALLIANCEBERNSTEIN INVESTOR SERVICES, INC., AT THE FOLLOWING ADDRESS: ALLIANCEBERNSTEIN L.P., 66 Hudson Boulevard East, ATTN: PRIVATE CLIENT, NEW YORK, N.Y. 10001; OR BY FAX TO (212) 407-5850. FOR ADDITIONAL INFORMATION CONTACT YOUR BERNSTEIN ADVISOR OR BERNSTEIN'S MAIN OFFICE AT (212) 486-5800.** 

**PART 1 Stockholder Information:** 

Name of Stockholder: *(account name)*<u> </u><u> </u><u> </u> <u> </u> <u> </u> <u> </u> <u> </u> <u> </u> 

Account Number:<u> </u> <u> </u> <u> </u><u> </u> <u> </u> <u> </u> <u> </u> <u> </u> <u> </u><u> </u> <u> </u><u> </u><u> </u>

**PART 2 Shares Being Tendered:** *(specify one)* 

☐ **All of the undersigned's Shares.** 

**<u>Effect on Remaining Capital Commitment</u>:** By electing this option, stockholders that entered into a Capital Commitment (as defined in the Offer to Purchase) on or before February 27, 2023 will be released from such Capital Commitment and, if all Shares are accepted, will no longer be stockholders in the Fund. 

**<u>Dividend Reinvestment Plan Election:</u>** If a stockholder has not opted in to the Dividend Reinvestment Plan, no action is necessary.

For stockholders that entered into a Capital Commitment on or before February 27, 2023, by virtue of delivery of this Notice of Intent to Tender, the election to tender all of the undersigned's Shares shall be deemed an instruction to the Fund to notify State Street Bank and Trust Company (the administrator of the Fund's Dividend Reinvestment Plan) of a change of election to have all dividends of the Fund paid in cash to the stockholder beginning with dividends payable on or after March 31, 2026.

For stockholders that have made Capital Commitments after February 27, 2023, the delivery of this Notice of Intent to Tender and tender of all of the undersigned's Shares shall not be deemed an instruction to the Fund to notify State Street Bank and Trust Company of a change of election under the Fund's dividend reinvestment plan, unless this box is checked to opt out of the Fund's dividend reinvestment plan: ☐

☐ **A portion of the undersigned's Shares expressed as the following percentage of current shareholdings: %.** 

**<u>Effect on Remaining Capital Commitment:</u>**

Stockholders that entered into a Capital Commitment (as defined in the Offer to Purchase) on or before February 27, 2023 will be released from such Capital Commitment unless they elect to keep their Capital Commitment in effect by selecting an option below:

☐ Maintain such Capital Commitment.

☐ Release from such Capital Commitment (*Default election if no election is made*).

☐ **The following number of Shares: .** 

<u>Effect on Remaining Capital Commitment:</u>

Stockholders that entered into a Capital Commitment (as defined in the Offer to Purchase) on or before February 27, 2023 will be released from such Capital Commitment unless they elect to keep their Capital Commitment in effect by selecting an option below:

☐ Maintain such Capital Commitment.

☐ Release from such Capital Commitment (*Default election if no election is made*).

------

**PART 3 Payment:** 

If you want to request that <u>100% of the cash payment of the note be sent to a single destination</u>, please check one option below and provide the relevant information:

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ Journal to Bernstein Account Number:  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ Check Payable to:  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mailing Address:  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ Wire or ACH Transfer (circle one)  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Destination Bank:  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ABA Routing Number or BIC/SWIFT:  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mailing Address:  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Recipient Institution**:  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Account Number:  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Recipient/For Credit to:** *(Account Title)*  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Account Number: *(if applicable)*  |

---

Alternatively, if you want to request that <u>cash payment of the note be divided among two or more destinations</u>, please provide the relevant instructions in this section, specifying amounts and percentages as needed:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

**PART 4 Signature(s)** 

By signing below, you acknowledge that you have received and reviewed the Offer to Purchase and that the Fund will execute your tender request as detailed in Parts 1-3 unless a Notice of Withdrawal is properly submitted prior to the Expiration Date outlined in the Offer to Purchase.

---

| | | |
|:---|:---|:---|
| Print Signatory Name and Title (if any) | Signature | Date |
| Print Signatory Name and Title (if more than one) | Signature | Date |
| Print Signatory Name and Title (if more than one) | Signature | Date |

---

------

![LOGO](g111092g39g39.jpg)

Fcrm W-9 Request for Taxpayer Give form to the (Rev. March 2024) Identification Number and Certification requester. Do not Department of the Treasury send to the IRS. Internal Revenue Service Go to www.irs.gov/FormW9 for instructions and the latest information. Before you begin. For guidance related to the purpose of Form W-9, see Purpose ofFonn, below . 1 Name of entity/individual. M entry is required. (For a sole proprietor or disregarded entity, enter the owner's name on line 1, and enter the business/disregarded entity's name on line 2.) 2 Business name/disregarded entity name, if different from above. ? 3a Check the appropriate box for federal tax classification of the entity!Individual whose name is entered on line 1. Check 4 Exemptions (codes apply only to "'01 only one ofthe following seven boxes. certain entities, not individuals; "'0. see instructions on page 3): c D Individual/sole proprietor D C corporation D S corporation D Partnership D TrusVestate 0 "'c:: ·"' D LLC. Enter the tax classification (C = C corporallon, S = S corporation, P = Partnership) —- Exempt payee code (if any) —— ~-52 Note: Check the "LLC" box above and, in the entry space, enter the appropriate code (C, S, or P) for the tax -t classification of the LLC, unless it is a disregarded entity. A disregarded entity should instead check t he appropriate Exemption from Forefgn Account Tax a 2 box fo r the tax classification of its owner. Compliance Act (I ATCA) reporting .§~ D Other (see instructions) code (1f any) 0. 0 ~ 3b If on line 3a you checked "Partnerst.p" cr 'Trust/estate," or checked "LLC" and entered "P" as its tax classlficallon, ~ and you are providing this form to a partnership, trust, or estate in which you have an ownership interest, check (Applies to accounts maintained &- this box if you have any foreign partners, owners, or beneficiaries. See instructions D outside the United States.) "' 5 Address (number, street, and apt. or su1te no.). See instructions. Requester's name and address (optional) (/)"' 6 City, state, and ZIP code 7 List account number(s) here (optionaQ ma Taxpayer Identification Number (TIN) [ Social security number I Enter your TIN in the appropriate box. The TIN provided must match the name given on line 1 to avoid backup Withholding. For 1nd1v1duals, th1s 1s generally your soc1al secunty number (SSN). How ever, for a resident alien, sole proprietor, or disregarded entity, see the instructions for Part I, later. For other ITIJ -ITJ -1I I I entities, it is your employer identification number (EIN). If you do not have a number, see How to get a or TIN. later. Note: If the account is in more than one name, see the instructions for line 1. See also What Name and Number To Give the Requester for guidelines on whose number to enter. Certification Under penalties of perjury, I certify that: 1. The number shown on this form is my correct taxpayer identification number (or I am waiting for a number to be issued to me); and 2. I am not subject to backup w ithholding becau se (a) I am exempt from backup withholding, or (b) I have not been notified by the Internal Revenue Service (IRS) that I am subject to backup withholding as a result of a failure to report all interest or dividends, or (c) the IRS has notified me that I am no longer subject to backup w ithholding ; and 3. I am a U.S. citizen or other U.S. person (defined below); and 4. The FATCA code(s) entered on this form Qf any) indicating that I am exempt from FATCA reporting is correct. Certification instructions. You must cross out item 2 above if you have been notified by the IRS that you are currently subject to backup withholding because you have failed to report all interest and dividends on your tax return. For real estate transactions, item 2 does not apply. For mortgage interest paid, acquisition or abandonment of secured property, cancellation of debt, contributions to an individual retirement arrangement (IRA), and, generally, payments other than interest and dividends, you are not required to sign the certification, but you must provide your correct TIN. See the instructions for Part II, later. Sign I Signature of Here . U.S. person Date General Instructions New line 3b has been added to t his form . A flow-through ent ity is required to complete this line to indicate t hat it has direct or indirect Section references are to the Internal Revenue Code unless otherwise foreign partners, owners, or b eneficiaries when it provides the Form W-9 noted. to another ftow -through entity in w hich it has an ownership interest. This Future developments . For the latest information about developments change is intended to provide a f low -through entity w ith information related to Form W-9 and its instructions, such as legislation enacted regarding the status of its indirect foreign partners, owners, or after they were published, go to www.irs.gov/FormW9. beneficiaries, s o that it can satisfy any applicable reporting requirements. For example, a p artnership that has any indirect foreign What's New partners may be required t o complete Schedules K-2 and K-3. See the Partnership Instructions for Schedules K-2 and K- 3 (Form 1 065). Line 3a has been modified to clarify how a disregarded entity completes this line. An LLC that is a disregarded entity should check the Purpose of Form appropriate box for the tax classification of its owner. Otherwise, it should check the "LLC" box and enter its appropriate tax classification. An individual or entity (Form W-9 requester) who is required t o file an information return w ith the IRS is giving you this form because they Cat. No. 10231X Fcrm W-9 (Rev. 3-2024) </FONT

------

![LOGO](g111092g40g40.jpg)

Form W-9 (Rev. 3-2024) Page 2 must obtain your correct taxpayer identification number (TIN), which Foreign person. If you are a foreign person or the U.S. branch of a may be your social security number (SSN), individual taxpayer foreign bank that has elected to be treated as a U.S. person (under identification number (IT IN), adoption taxpayer identification number Regulations section 1.1441-1 (bX2)(iv) or other applicable section for (ATIN), or employer identification number (EIN), to report on an chapter 3 or 4 purposes), do not use Form W-9. Instead, use the information return the amount paid to you, or other amount reportable appropriate Form W-8 or Form 8233 (see Pub. 515). If you are a on an information return. Examples of information returns include, but qualified foreign pension fund under Regulations section 1.897(1)-1 (d), or are not limited to, the following. a partnership that is wholly owned by qualified foreign pension funds, that is treated as a non-foreign person for purposes of section 1445 • Form 1099-INT (interest earned or paid). withholding, do not use Form W-9. Instead, use Form W-8EXP (or other • Form 1099-DIV (dividends, including those from stocks or mutual funds). certification of non-foreign status). • Form 1099-MISC (various types of income, prizes, awards, or gross Nonresident alien who becomes a resident alien. Generally, only a proceeds). nonresident alien individual may use the terms of a tax treaty to reduce or eliminate U.S. tax on certain types of income. However, most tax • Form 1099-NEC (nonemployee compensation). treaties contain a provision known as a saving clause. Exceptions specified in the saving clause may permit an exemption from tax to • Form 1099-B (stock or mutual fund sales and certain other continue for certain types of income even after the payee has otherwise transactions by brokers). become a U.S. resident alien for tax purposes. • Form 1099-S (proceeds from real estate transactions). If you are a U.S. resident alien who is relying on an exception • Form 1099-K (merchant card and third-party network transactions). contained in the saving clause of a tax treaty to claim an exemption • Form 1098 (home mortgage interest), 1098-E (student loan interest), from U.S. tax on certain types of income, you must attach a statement and 1098-T (tuition). to Form W-9 that specifies the following five items. • Form 1099-C (canceled debt). 1. The treaty country. Generally, this must be the same treaty under which you claimed exemption from tax as a nonresident alien. • Form 1099-A (acquisition or abandonment of secured property). 2. The treaty article addressing the income. Use Form W-9 only if you are a U S. person (including a resident alien), to provide your correct TIN. 3. The article number (or location) in the tax treaty that contains the saving clause and its exceptions. Caution: If you don't return Form W-9 to the requester with a TIN, you might be subject to backup withholding. See What is backup 4. The type and amount of income that qualifies for the exemption withholding, later. from tax. By signing the filled-out form, you: 5. Sufficient facts to justify the exemption from tax under the terms of the treaty article. 1. Certify that the TIN you are giving is correct (or you are waiting for a number to be issued); Example. Article 20 of the U.S.-China income tax treaty allows an exemption from tax for scholarship income received by a Chinese 2. Certify that you are not subject to backup withholding; or student temporarily present in the United States. Under U.S. law, this 3. Claim exemption from backup withholding if you are a U.S. exempt payee; and student w ill become a resident alien for tax purposes if their stay in the United States exceeds 5 calendar years. However, paragraph 2 of the 4. Certify to your non-foreign status for purposes of withholding under first Protocol to the U.S.-China treaty (dated April 30, 1984) allows the chapter 3 or 4 of the Code (if applicable); and provisions of Article 20 to continue to apply even after the Chinese student becomes a resident alien of the United States. A Chinese 5. Certify that FATCA code(s) entered on this form (if any) indicating student w ho qualifies for this exception (under paragraph 2 of the first that you are exempt from the FATCA reporting is correct. See What /s Protocol) and is relying on this exception to claim an exemption from tax FATCA Reporting, later, for further information. Note: If you are a U.S. person and a requester gives you a form other on their scholarship or fellowship income would attach to Form W-9 a than Form W-9 to request your TIN, you must use the requester's form if statement that includes the information described above to support that it is substantially similar to this Form W-9. exemption. Definition of a U.S. person. For federal tax purposes, you are If you are a nonresident alien or a foreign entity, give the requester the considered a U.S. person if you are: appropriate completed Form W-8 or Form 8233. • An individual who is a U.S. citizen or U.S. resident alien; Backup Withholding • A partnership, corporation, company, or association created or What is backup withholding? Persons making certain payments to you organized in the United States or under the laws of the United States; must under certain conditions withhold and pay to the IRS 24% of such • An estate (other than a foreign estate); or payments. This is called "backup withholding." Payments that may be subject to backup withholding include, but are not limited to, interest, • A domestic trust (as defined in Regulations section 301. 7701-7). tax-exempt interest, dividends, broker and barter exchange Establishing U.S. status for purposes of chapter 3 and chapter 4 transactions, rents, royalties, nonemployee pay, payments made in withholding. Payments made to foreign persons, including certain settlement of payment card and third-party network transactions, and distributions, allocations of income, or transfers of sales proceeds, may certain payments from fishing boat operators. Real estate transactions be subject to withholding under chapter 3 or chapter 4 of the Code are not subject to backup withholding. (sections 1441- 1474). Under those rules, if a Form W-9 or other You w ill not be subject to backup withholding on payments you receive certification of non-foreign status has not been received, a withholding if you give the requester your correct TIN, make the proper certifications, agent, transferee, or partnership (payor) generally applies presumption and report all your taxable interest and dividends on your tax return. rules that may require the payor to withhold applicable tax from the recipient, owner, transferor, or partner (payee). See Pub. 515, Payments you receive will be subject to backup withholding if: Withholding of Tax on Nonresident Aliens and Foreign Entities. 1. You do not furnish your TIN to the requester; The following persons must provide Form W-9 to the payor for 2. You do not certify your TIN when required (see the instructions for purposes of establishing its non-foreign status. Part II for details); • In the case of a disregarded entity with a U.S. owner, the U.S. owner 3. The IRS tells the requester that you furnished an incorrect TIN; of the disregarded entity and not the disregarded entity 4. The IRS tells you that you are subject to backup withholding • In the case of a grantor trust with a U.S. grantor or other U.S. owner, because you did not report all your interest and dividends on your tax generally, the U.S. grantor or other U.S. owner of the grantor trust and return (for reportable interest and dividends only); or not the grantor trust. 5. You do not certify to the requester that you are not subject to • In the case of a U.S. trust (other than a grantor trust), the U.S. trust backup w ithholding, as described in item 4 under "By signing the filled-and not the beneficiaries of the trust. out fonn" above (for reportable interest and dividend accounts opened See Pub. 515 for more information on providing a Form W-9 or a after 1983 only). certification of non-foreign status to avoid withholding.

------

![LOGO](g111092g41g41.jpg)

Form W-9 (Rev. 3-2024) Page 3 Certain payees and payments are exempt from backup withholding. example, if a foreign LLC that is treated as a disregarded entity for U.S. See Exempt payee code, later, and the separate Instructions for the federal tax purposes has a single owner that is aU S. person, the US. Requester of Form W-9 for more information. owner's name is required to be provided on line 1. If the direct owner of the entity is also a disregarded entity, enter the first owner that is not See also Establishing U.S. status for purposes of chapter 3 and disregarded for federal tax purposes. Enter the disregarded entity 's chapter 4 withholding, earlier. name on line 2. If the owner of the disregarded entity is a foreign person, What Is FATCA Reporting? the owner must complete an appropriate Form W-8 instead of a Form W-9. This is the case even if the foreign person has a U.S. TIN. The Foreign Account Tax Compliance Act (FATCA) requires a participating foreign financial institution to report all U.S. account Line 2 holders that are specified U.S. persons. Certain payees are exempt from If you have a business name, trade name, DBA name, or disregarded FATCA reporting. See Exemption from FATCA reporting code, later, and entity name, enter it on line 2. the Instructions for the Requester of Form W-9 for more information. Line 3a Updating Your Information Check the appropriate box on line 3a for the U.S. federal tax You must provide updated information to any person to whom you classification of the person whose name is entered on line 1. Check only claimed to be an exempt payee if you are no longer an exempt payee one box on line 3a. and anticipate receiving reportable payments in the future from this IF the entity/individual on line 1 THEN check the box for person. For example, you may need to provide updated information if is a(n) .. . you are a C corporation that elects to be an S corporation, or if you are no longer tax exempt. In addition, you must furnish a new Form W-9 if • Corporation Corporation. the name or TIN changes for the account, for example, if the grantor of a • Individual or Individual/sole proprietor. grantor trust dies. • Sole proprietorship Penalties • LLC classified as a partnership Limited liability company and for U.S. federal tax purposes or enter the appropriate tax Failure to furnish TIN.If you fail to furnish your correct TIN to a classification: requester, you are subject to a penalty of $50 for each such failure • LLC that has filed Form 8832 or unless your failure is due to reasonable cause and not to willful neglect. 2553 electing to be taxed as a P = Partnership, corporation C = C corporation, or Civil penalty for false information with respect to withholding. If you S = S corporation. make a false statement with no reasonable basis that results in no backup withholding, you are subject to a $500 penalty. • Partnership Partnership. Criminal penalty for falsifying information. Willfully falsifying • Trust/estate Trust/estate. certifications or affirmations may subject you to criminal penalties including fines and/or imprisonment. Line 3b Misuse of TINs. If the requester discloses or uses TINs in violation of Check this box if you are a partnership (including an LLC classified as a federal law, the requester may be subject to civil and criminal penalties. partnership for U.S. federal tax purposes), trust, or estate that has any foreign partners, owners, or beneficiaries, and you are providing this Specific Instructions form to a partnership, trust, or estate, in which you have an ownership interest. You must check the box on line 3b if you receive a Form W-8 Line 1 (or documentary evidence) from any partner, owner, or beneficiary You must enter one of the following on this line; do not leave this line establishing foreign status or if you receive a Form W-9 from any blank. The name should match the name on your tax return. partner, owner, or beneficiary that has checked the box on line 3b. If this Form W-9 is for a joint account (other than an account Note: A partnership that provides a Form W-9 and checks box 3b may maintained by a foreign financial institution (FFI)), list first, and then be required to complete Schedules K-2 and K-3 (Form 1065) . For more circle, the name of the person or entity whose number you entered in information, see the Partnership Instructions for Schedules K-2 and K-3 Part I of Form W-9. If you are providing Form W-9 to an FFI to document (Form 1065). If you are required to complete line 3b but fail to do so, you may not a joint account, each holder of the account that is a U.S. person must receive the information necessary to file a correct information return with provide a Form W-9. the IRS or furnish a correct payee statement to your partners or • Individual. Generally, enter the name shown on your tax return. If you have changed your last name without informing the Social Security beneficiaries. See, for example, sections 6698, 6722, and 6724 for Administration (SSA) of the name change, enter your first name, the last penalties that may apply. name as shown on your social security card, and your new last name. Line 4 Exemptions Note for ITIN applicant: Enter your individual name as it was entered If you are exempt from backup withholding and/or FATCA reporting, on your Form W-7 application, line 1a. This should also be the same as enter in the appropriate space on line 4 any code(s) that may apply to the name you entered on the Form 1040 you filed with your application. you • Sole proprietor. Enter your individual name as shown on your Form Exempt payee code. 1040 on line 1. Enter your business, trade, or "doing business as" (DBA) • Generally, individuals (including sole proprietors) are not exempt from name on line 2. backup withholding. • Partnership, C corporation, S corporation, or LLC, other than a • Except as provided below, corporations are exempt from backup disregarded entity. Enter the entity's name as shown on the entity's tax withholding for certain payments, including interest and dividends. return on line 1 and any business, trade, or DBA name on line 2. • Other entities. Enter your name as shown on required U.S. federal tax • Corporations are not exempt from backup withholding for payments documents on line 1. This name should match the name shown on the made in settlement of payment card or third-party network transactions. charter or other legal document creating the entity. Enter any business, • Corporations are not exempt from backup withholding with respect to trade, or DBA name on line 2. attorneys' fees or gross proceeds paid to attorneys, and corporations that provide medical or health care services are not exempt with respect • Disregarded entity. In general, a business entity that has a single to payments reportable on Form 1099-MISC. owner, including an LLC, and is not a corporation, is disregarded as an entity separate from its owner (a disregarded entity). See Regulations The following codes identify payees that are exempt from backup section 301. 7701-2(c)(2). A disregarded entity should check the withholding. Enter the appropriate code in the space on line 4. appropriate box for the tax classification of its owner. Enter the owner's 1-An organization exempt from tax under section 501 (a), any IRA, or name on line 1. The name of the owner entered on line 1 should never a custodial account under section 403(b)(7) if the account satisfies the be a disregarded entity. The name on line 1 should be the name shown requirements of section 401(f)(2). on the income tax return on which the income should be reported. For

------

![LOGO](g111092g42g42.jpg)

Form W-9 (Rev. 3-2024) Page 4 2-The United States or any of its agencies or instrumentalities. F-A dealer in securities, commodities, or derivative financial instruments Qncluding notional principal contracts, futures, forwards, 3-A state, the District of Columbia, a U.S. commonwealth or territory, and options) that is registered as such under the laws of the United or any of their political subdivisions or instrumentalities. States or any state. 4-A foreign government or any of its political subdivisions, agencies, G-A real estate investment trust. or instrumentalities. H-A regulated investment company as defined in section 851 or an 5-A corporation. entity registered at all times during the tax year under the Investment 6-A dealer in securities or commodities required to register in the United States, the District of Columbia, or a U.S. commonwealth or Company Act of 1940. 1-A common trust fund as defined in section 584(a). territory. J-A bank as defined in section 581. 7 -Afutures commission merchant registered with the Commodity Futures Trading Commission. K-A broker. 8-A real estate investment trust. L-A trust exempt from tax under section 664 or described in section 4947(a)(1). 9-An entity registered at all times during the tax year under the Investment Company Act of 1940. M—A tax-exempt trust under a section 403(b) plan or section 457(g) plan. 10-A common trust fund operated by a bank under section 584(a). Note: You may wish to consult with the financial institution requesting 11 -Afinancial institution as defined under section 581. this form to determine whether the FATCA code and/or exempt payee 12 -Amiddleman known in the investment community as a nominee or custodian. code should be completed. 13 -Atrust exempt from tax under section 664 or described in section Line 5 4947. Enter your address (number, street, and apartment or suite number). The following chart shows types of payments that may be exempt This is where the requester of this Form W-9 will mail your information from backup withholding. The chart applies to the exempt payees listed returns. If this address differs from the one the requester already has on above, 1 through 13. file, enter "NEW" at the top. If a new address is provided, there is still a chance the old address will be used until the payor changes your IF the payment is for ... THEN the payment is exempt address in their records. for • Interest and dividend payments All exempt payees except Line 6 for 7. Enter your city, state, and ZIP code. • Broker transactions Exempt payees 1 through 4 and 6 Part I. Taxpayer Identification Number (TIN) through 11 and all C corporations. S corporations must not enter an Enter your TIN in the appropriate box. If you are a resident alien and exempt payee code because they you do not have, and are not eligible to get, an SSN, your TIN is your are exempt only for sales of IRS IT IN. Enter it in the entry space for the Social security number. If you noncovered securities acquired do not have an IT IN, see How to get a TIN below. prior to 2012. If you are a sole proprietor and you have an EIN, you may enter either • Barter exchange transactions Exempt payees 1 through 4. your SSN or EIN. and patronage dividends If you are a single-member LLC that is disregarded as an entity • Payments over $600 required to Generally, exempt payees separate from its owner. enter the owner's SSN (or EIN, if the owner has be reported and direct sales over 1 through 5. 2 one). If the LLC is classified as a corporation or partnership, enter the 1 entity's EIN. $5,000 Note: See What Name and Number To Give the Requester, later, for • Payments made in settlement of Exempt payees 1 through 4. further clarification of name and TIN combinations. payment card or third-party network transactions How to get a TIN. If you do not have a TIN, apply for one immediately. 1 To apply for an SSN, get Form SS-5, Application for a Social Security See Form 1099-MISC, Miscellaneous Information, and its instructions. 2 Card, from your local SSA office or get this form online at However, the following payments made to a corporation and www.SSAgov. You may also get this form by calling 800-772-1213. Use reportable on Form 1099-MISC are not exempt from backup Form W-7, Application for IRS Individual Taxpayer Identification withholding: medical and health care payments, attorneys' fees, gross Number, to apply for an IT IN, or Form SS-4, Application for Employer proceeds paid to an attorney reportable under section 6045(1), and Identification Number, to apply for an EIN. You can apply for an EIN payments for services paid by a federal executive agency. online by accessing the IRS website at www.irs.gov/EIN. Go to Exemption from FATCA reporting code. The following codes identify www.irs.gov/Forms to view, download, or print Form W-7 and/or Form payees that are exempt from reporting under FAT CA. These codes SS-4. Or, you can go to www.irs.gov/OrderForms to place an order and apply to persons submitting this form for accounts maintained outside have Form W-7 and/or Form SS-4 mailed to you within 15 business of the United States by certain foreign financial institutions. Therefore, if days. you are only submitting this form for an account you hold in the United If you are asked to complete Form W-9 but do not have a TIN, apply States, you may leave this field blank. Consult with the person for a TIN and enter "Applied For" in the space for the TIN, sign and date requesting this form if you are uncertain if the financial institution is the form, and give it to the requester. For interest and dividend subject to these requirements. A requester may indicate that a code is payments, and certain payments made with respect to readily tradable not required by providing you with a Form W-9 with "Not Applicable" (or instruments, you will generally have 60 days to get a TIN and give it to any similar indication) entered on the line for a FATCA exemption code. the requester before you are subject to backup withholding on A- An organization exempt from tax under section 501 (a) or any payments. The 60-day rule does not apply to other types of payments. individual retirement plan as defined in section 7701 (a)(37). You will be subject to backup withholding on all such payments until you provide your TIN to the requester. B-The United States or any of its agencies or instrumentalities. Note: Entering "Applied For" means that you have already applied for a C-A st ate, the District of Columbia, a U.S. commonwealth or TIN or that you intend to apply for one soon. See also Establishing U.S. territory, or any of their political subdivisions or instrumentalities. status for purposes ofchapter 3 and chapter 4 withholding, earlier, for D-A corporation the stock of which is regularly traded on one or when you may instead be subject to withholding under chapter 3 or 4 of more established securities markets, as described in Regulations the Code. section 1.1472-1(c)(1Xi). Caution: A disregarded U.S. entity that has a foreign owner must use E- A corporation that is a member of the same expanded affiliated the appropriate Form W-8. group as a corporation described in Regulations section 1.1472-1(cX1)(i).

------

![LOGO](g111092g43g43.jpg)

Form W-9 (Rev. 3-2024) Page 5 Part II. Certification For this type of account: Give name and EIN of: To establish to the withholding agent that you are a U.S. person, or 8. Disregarded entity not owned by an The owner resident alien, sign Form W-9. You may be requested to sign by the individual withholding agent even if item 1, 4, or 5 below indicates otherwise. 9. A valid trust, estate, or pension trust Legal entity' For a joint account, only the person whose TIN is shown in Part I 10. Corporation or LLC electing corporate The corporation should sign (when required). In the case of a disregarded entity, the status on Form 8832 or Form 2553 person identified on line 1 must sign. Exempt payees, see Exempt payee 11 Association, club, religious, charitable, The organization code, earlier. educational, or other tax-exempt organization Signature requirements. Complete the certification as indicated in items 1 through 5 below. 12. Partnership or mult i-member LLC The partnership 1. Interest, dividend, and barter exchange accounts opened 13. A broker or registered nominee The broker or nominee before 1984 and broker accounts considered active during 1983. 14. Account with t he Department of The public entity You must give your correct TIN, but you do not have to sign the Agriculture in the name of a public certification. entity (such as a state or local 2. Interest, dividend, broker, and barter exchange accounts government, school district, or prison) that receives agricultural program opened after 1983 and broker accounts considered inactive during payments 1983. You must sign the certification or backup withholding will apply. If 15. Grantor trust filing Form 1041 or The trust you are subject to backup withholding and you are merely providing your correct TIN to the requester, you must cross out item 2 in the under the Optional Filing Method 2, requiring Form 1099 (see Regulations certification before signing the form. section 1.671-4(b)(2)(i)(B))"" 3. Real estate transactions. You must sign the certification. You may 1 List first and circle the name of the person whose number you furnish. cross out item 2 of the certification. If only one person on a joint account has an SSN, that person's number 4. Other payments. You must give your correct TIN, but you do not must be furnished. have to sign the certification unless you have been notified that you 2 Circle the minor's name and furnish the minor's SSN. have previously given an incorrect TIN. "Other payments" include payments made in the course of the requester's trade or business for ' You must show your individual name on line 1, and enter your business rents, royalties, goods (other than bills for merchandise), medical and or DBA name, if any, on line 2. You may use either your SSN or EIN (if health care services Oncluding payments to corporations), payments to you have one), but the IRS encourages you to use your SSN. a non employee for services, payments made in settlement of payment 4 card and third-party network transactions, payments to certain fishing List first and circle the name of the trust, estate, or pension trust. (Do boat crew members and fishermen, and gross proceeds paid to not furnish the TIN of the personal representative or trustee unless the attorneys (including payments to corporations). legal entity itself is not designated in the account title.) 5. Mortgage interest paid by you, acquisition or abandonment of · Note: The grantor must also provide a Form W-9 to the trustee of the secured property, cancellation of debt, qualified tuition program trust. \*\* For more information on optional filing methods for grantor trusts, see payments (under section 529), ABLE accounts (under section 529A), the Instructions for Form 1041. IRA, Coverdell ESA, Archer MSA or HSA contributions or distributions, and pension distributions. You must give your correct Note: If no name is circled when more than one name is listed, the TIN, but you do not have to sign the certification. number will be considered to be that of the first name listed. What Name and Number To Give the Requester Secure Your Tax Records From Identity Theft For this type of account: Give name and SSN of: Identity theft occurs when someone uses your personal information, such as your name, SSN, or other identifying information, without your 1. lndivid ual The individual 2. Two or more individuals ijoint account) The actual owner of the account or, permission to commit fraud or other crimes. An identity thief may use your SSN to get a job or may file a tax return using your SSN to receive other than an account maintained by if combined funds, the first individual a refund. an FFI on the account' To reduce your risk: 3. Two or more U.S. persons Each holder of the account ijoint account maintained by an FFI) • Protect your SSN, 4. Custodial account of a mrnor The minor2 • Ensure your employer is protecting your SSN, and (Uniform Gift to Minors Act) • Be careful when choosing a tax return preparer. 5. a. The usual revocable savings trust The grantor-trustee 1 If your tax records are affected by identity theft and you receive a (grantor is also trustee) b. So-called trust account that is not The act ual owner 1 notice from the IRS, respond right away to the name and phone number printed on the IRS notice or letter. a legal or valid trust under state law 3 If your tax records are not currently affected by identity theft but you 6. Sole propnetorshrp or drsregarded The owner think you are at risk due to a lost or stolen purse or wallet, questionable entity owned by an indrvidual Optronal credit card activity, or a questionable credit report, contact the IRS 7. Grantortrustflling under The grant or"' Identity Theft Hotline at 800-908-4490 or submit Form 14039. Filing M ethod 1 (see Regulations section 1.671-4(b)(2)(i)(A))" For more information, see Pub. 5027, Identity Theft Information for Taxpayers.

------

![LOGO](g111092g44g44.jpg)

Form W-9 (Rev. 3-2024) Page 6 Victims of identity theft who are experiencing economic harm or a Privacy Act Notice systemic problem, or are seeking help in resolving tax problems that have not been resolved through normal channels, may be eligible for Section 6109 of the Internal Revenue Code requires you to provide your Taxpayer Advocate Service (TAS) assistance. You can reach TAS by correct TIN to persons Qncluding federal agencies) who are required to calling theTAS toll-free case intake line at 877-777-4778 or TTY!TDD file information returns with the IRS to report interest, dividends, or 800-829-4059. certain other income paid to you; mortgage interest you paid; the acquisition or abandonment of secured property; the cancellation of Protect yourself from suspicious emails or phishing schemes. debt; or contributions you made to an IRA, Archer MSA, or HSA. The Phishing is the creation and use of email and websites designed to person collecting this form uses the information on the form to file mimic legitimate business emails and websites. The most common act information returns with the IRS, reporting the above information. is sending an email to a user falsely claiming to be an established Routine uses of this information include giving it to the Department of legitimate enterprise in an attempt to scam the user into surrendering Justice for civil and criminal litigation and to cities, states, the District of private information that will be used for identity theft Columbia, and U.S. commonwealths and territories for use in The IRS does not initiate contacts with taxpayers via emails. Also, the administering their laws. The information may also be disclosed to other IRS does not request personal detailed information through email or ask countries under a treaty, to federal and state agencies to enforce civil taxpayers for the PIN numbers, passwords, or similar secret access and criminal laws, or to federal law enforcement and intelligence information for their credit card, bank, or other financial accounts. agencies to combat terrorism. You must provide your TIN whether or not If you receive an unsolicited email claiming to be from the IRS, you are required to file a tax return. Under section 3406, payors must forward this message to phishing@irs.gov. You may also report misuse generally withhold a percentage of taxable interest, dividends, and of the IRS name, logo, or other IRS property to the Treasury Inspector certain other payments to a payee who does not give a TIN to the payor. General for Tax Administration (TIGTA) at 800-366-4484. You can Certain penalties may also apply for providing false or fraudulent forward suspicious em ails to the Federal Trade Commission at information. spam@uce.gov or report them at w.vw.ftc.gov!complaint. You can contact the FTC at www.ftc.gov/idtheft or 877-IDTHEFT (877-438-4338). If you have been the victim of identity theft, see www.ldentityTheft.gov and Pub. 5027. Go to www.irs.gov/ldentityTheft to learn more about identity theft and how to reduce your risk.

## Ex-99.(A)(1)(C)

**Exhibit (a)(1)(C)** 

**NOTICE OF WITHDRAWAL OF TENDER** 

**REGARDING** 

**SHARES** 

**OF** 

**AB PRIVATE CREDIT INVESTORS CORPORATION** 

**Tendered Pursuant to the Offer to Purchase Dated February 27, 2026** 

**THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT, AND THIS NOTICE OF WITHDRAWAL OF TENDER MUST BE RECEIVED BY 5:00 P.M., EASTERN TIME, ON MARCH 31, 2026, UNLESS THE OFFER IS EXTENDED.** 

**Complete this Notice of Withdrawal of Tender and return or deliver it to your Bernstein advisor. If you do not have a Bernstein advisor, you may return it to: 66 Hudson Boulevard East, Attn: Private Client, New York 10001; or fax it to (212) 407-5850.** 

**For additional information, call your Bernstein advisor.** 

**You may also direct questions to the main office of Bernstein at (212) 486-5800.** 

**AB Private Credit Investors Corporation** 

Ladies and Gentlemen:

The undersigned wishes to withdraw the previously submitted notice of the undersigned's intent to tender its Shares of AB Private Credit Investors Corporation (the "Fund") for purchase by the Fund that previously was submitted by the undersigned in a Notice of Intent to Tender dated ___________. IF THIS WITHDRAWAL NOTICE IS TIMELY RECEIVED IN ACCORDANCE WITH ITS ACCOMPANYING INSTRUCTIONS, THE IDENTIFIED SHARES PREVIOUSLY SUBMITTED FOR TENDER WILL NOT BE PURCHASED BY THE FUND.

**AB PCIC Account No: <u> </u>** 

**Such tender is with respect to (specify one):** 

☐ All of the undersigned's Shares.

☐ The following number of Shares: .

☐ A portion of the undersigned's Shares expressed as the following percentage of current shareholdings: %. 

The undersigned recognizes that upon the submission on a timely basis of this Notice of Withdrawal of Tender, properly executed, the Shares previously tendered will not be purchased by the Fund upon expiration of the tender offer described above.

------

SIGNATURE(S). If joint ownership, all parties must sign. If fiduciary, partnership or corporation, indicate title of signatory under signature lines.

---

| | | |
|:---|:---|:---|
| Print Signatory Name and Title (if any) | Signature | Date |
| Print Signatory Name and Title (if more than one) | Signature | Date |
| Print Signatory Name and Title (if more than one) | Signature | Date |

---

## Ex-99.(A)(1)(D)

**Exhibit (a)(1)(D)** 

**FORM OF PROMISSORY NOTE** 

**NON-NEGOTIABLE PROMISSORY NOTE** 

**AB PRIVATE CREDIT INVESTORS CORPORATION** 

Dated: [•]

FOR VALUE RECEIVED, AB Private Credit Investors Corporation ("Payor" or the "Fund"), a Maryland corporation issuing its shares of common stock, par value $0.01 per share ("Shares"), hereby promises individually to each of the payees set forth on <u>Exhibit A</u> hereto (each, a "Payee") to pay the Payment Amount (as defined in Section 2) payable with respect to that Payee. This Note shall be deemed a separate instrument issued individually with respect to each Payee.

This Note is being issued so that Payor may purchase Shares (the "Purchased Shares") from the Payees pursuant to the terms and subject to the conditions set out in the Offer to Purchase dated February 27, 2026 and the Notice of Intent to Tender submitted by each Payee (which Offer to Purchase and Notice of Intent to Tender, together with any amendments or supplements thereto, collectively constitute the "Offer"). This Note is not negotiable and is not interest-bearing.

1. <u>General Payment Provisions</u>. The Payor will make the payments under this Note in cash in a single installment (except as otherwise provided in Section 2 below) in such currency of the United States of America as will be legal tender at the time of payment. Payment under this Note will be made by immediately available funds to Payee's account.

2. <u>Payment</u>. The "Payment Amount" for each Payee will be an amount equal to the value of the Payee's Purchased Shares determined as of March 31, 2026 (such date, as it may be extended, the "Expiration Date") (and valued in accordance with the Fund's private placement memorandum and subscription agreement). The Payor will make payment under this Note approximately 45 days after the Expiration Date.

3. <u>Optional Prepayment</u>. This Note may be prepaid, without premium, penalty or notice, at any time.

4. <u>Events of Default</u>.

(a) The occurrence of any of the following events shall be deemed to be an "Event of Default" under this Note; *provided, however*, that an event of default with respect to one Payee shall not in and of itself cause an event of default with respect to any other Payee:

(i) The Payor defaults in payment when due to the applicable Payee and any such default continues for a period of ten (10) days; or

(ii) The Payor shall commence any proceeding or other action relating to Payor in bankruptcy or seeking reorganization, arrangement, readjustment, dissolution, liquidation, winding-up, relief or composition of the Payor or the debts of the Payor under any law relating to bankruptcy, insolvency or reorganization or relief of debtors; the Payor applies for, or consents or acquiesces to, the appointment of a receiver, conservator, trustee or similar officer for the Payor or for all or substantially all of the property of the Payor; the Payor makes a general assignment for the benefit of creditors of the Payor; or the Payor generally admits its inability to pay its debts as they become due and payable; or

(iii) The commencement of any proceeding or the taking of any other action against Payor in bankruptcy or seeking reorganization, arrangement, readjustment, dissolution, liquidation, winding-up, relief or composition of the Payor or the debts of the Payor under any law relating to bankruptcy, insolvency or reorganization or relief of debtors and the continuance of any of such events for sixty (60) days undismissed, unbonded or undischarged; or the appointment of a receiver, conservator, trustee or similar officer for the Payor or for all or substantially all of the property of the Payor and the continuance of any such event for sixty (60) days undismissed, unbonded or undischarged.

(b) Upon the occurrence of an Event of Default, the entire unpaid amount of this Note outstanding shall become immediately due and payable, without presentment, demand, protest, or other notice of any kind, all of which are expressly waived, and without any action on the part of the Payee. This Note may be entitled to the benefits of a security agreement imposing a lien on certain of the Fund's assets. The lien under the security agreement may be released upon the terms set forth in the security agreement.

------

5. <u>Miscellaneous</u>.

(a) <u>Governing Law; Consent to Jurisdiction</u>. This Note and the rights and remedies of the Payor and each Payee will be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and to be wholly performed within such State, without regard to the conflict of laws principles of such State. Any legal action, suit or proceeding arising out of or relating to this Note may be instituted in any state or federal court located within the County of New York, State of New York, and each party hereto agrees not to assert, by way of motion, as a defense, or otherwise, in any such action, suit or proceeding, any claim that it is not subject personally to the jurisdiction of such court, that the venue of the action, suit or proceeding is improper or that this Note or the subject matter hereof may not be enforced in or by such court.

(b) <u>Notices</u>. All communications under this Note will be given in writing, sent by telecopier or registered mail, to the address set forth below in the case of the Payor, or to the address of the Payee set forth on <u>Exhibit A</u> hereto in the case of a Payee, or to such other address as such party will have specified in writing to the other party hereto, and will be deemed to have been delivered effective at the earlier of its receipt or within two (2) days after dispatch.

Payor address: AB Private Credit Investors Corporation 66 Hudson Boulevard East New York, NY 10001 Phone: 1-212-969-1000 Attention: Leon Hirth

(c) <u>Severability, Binding Effect</u>. Any provision of this Note that is prohibited or unenforceable in any jurisdiction will, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction will not invalidate or render unenforceable such provision in any other jurisdiction.

(d) <u>Amendment; Waiver</u>. No provision of this Note may be waived, altered or amended with respect to any Payee, except by written agreement between the Payor and such Payee.

(e) <u>Waiver of Presentment</u>. Payor hereby waives presentment, protest, demand for payment and notice of default or nonpayment to or upon Payor with respect to this Note.

(f) <u>Entire Agreement</u>. This Note and the Offer set out the entire agreement between the parties and supersede any prior oral or written agreement between the parties.

(g) <u>Separate Obligations</u>. The obligations of the Payor to each Payee hereunder are separate rather than joint, and a Payee may seek payment or the enforcement of any obligation of the Payor under this Note only with respect to itself and not any other Payee hereunder.

------

IN WITNESS WHEREOF, Payor has duly caused this Note to be duly executed as of the date first above written.

---

| | |
|:---|:---|
| AB PRIVATE CREDIT INVESTORS CORPORATION | AB PRIVATE CREDIT INVESTORS CORPORATION |
| By: |  |
|  | Name:<br> Title: |

---

*[Signature Page to Promissory Note]* 

------

<u>Exhibit A</u> 

Payees

---

| | | |
|:---|:---|:---|
| Name | Address | Address |
|  [ ] |  | [ ] |
|  [ ] |  | [ ] |

---

## Ex-99.(A)(5)(A)

**Exhibit (a)(5)(A)** 

**AB PRIVATE CREDIT INVESTORS CORPORATION** 

**Notice of Offer to Purchase for Cash** 

**Up to 1,861,300.28 Shares of its Common Stock** 

**at a Purchase Price Per Share of Common Stock Equal to** 

**its Net Asset Value per Share as of March 31, 2026** 

**THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON** 

**MARCH 31, 2026, UNLESS THE OFFER IS EXTENDED OR WITHDRAWN.** 

AB Private Credit Investors Corporation, an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended (the "***Fund***"), is offering to purchase for cash up to 1,861,300.28 of its shares of common stock, par value $0.01 per share (the "***Shares***"), at a price per Share equal to the Fund's net asset value per Share as of March 31, 2026 (the "***Purchase Price***").

If stockholders would like the Fund to purchase their Shares within the limits more fully set forth in the Fund's Offer to Purchase, dated February 27, 2026 (the "***Offer to Purchase***"), and the related Notice of Intent to Tender (the "***Notice of Intent***," and together with the Offer to Purchase, as each may be amended or supplemented from time to time, the "***Offer***"), they should contact their financial advisor or the Bernstein Global Wealth Management unit of AllianceBernstein L.P. ("***Bernstein***") at (212) 486-5800 to request that written materials relating to the Offer be provided to them. These written materials, which will be sent at no expense to the stockholder, include the Offer to Purchase and a Notice of Intent to Tender. A tendering stockholder must complete, sign, and mail (certified mail return receipt requested is recommended), fax, email or hand deliver the Notice of Intent to the Fund's agent specified therein, so that it is received before the Expiration Date stated below.

Stockholders who desire to tender Shares for purchase must do so by 5:00 p.m., New York time on March 31, 2026 (such date, as it may be extended, the "***Expiration Date***"). All determinations as to the receipt of notices from stockholders relating to the tender of Shares, including, without limitation, determinations whether to excuse or waive certain variations from relevant procedural requirements, will be in the sole discretion of the Fund or its designated agents, and any such determination will be final.

The purpose of the Offer is to provide liquidity to stockholders because the Shares are not listed on any securities exchange. The Offer is not conditioned upon the tender of any minimum number of Shares or any financing condition.

The Fund is offering to purchase up to 2.5% of the weighted average of the number of Shares outstanding during the three-month period ended December 31, 2025 (the "***Quarterly Tender Cap***"). The Fund is not required to purchase any tendered Shares in excess of the Quarterly Tender Cap and, therefore, the Fund is not required to purchase any tendered Shares to the extent those Shares are, in the aggregate, in excess of 1,861,300.28. In accordance with rules promulgated by the Securities and Exchange Commission (the "***SEC***"), the Fund may increase the number of Shares accepted for payment in the Offer by up to, but not more than, 2% of the outstanding Shares without amending or extending the Offer.

It is anticipated that the purchase of Shares tendered by a stockholder will be a taxable transaction for U.S. federal income tax purposes. Participating stockholders should consult their tax advisor regarding specific tax implications, including potential federal, state, local and foreign tax consequences.

Until the Expiration Date, stockholders have the right to withdraw any tenders of their Shares by giving proper notice to the Fund. Shares withdrawn may be re-tendered before the Expiration Date by following the tender procedures. If the Fund has not yet accepted a stockholder's tender of Shares on or prior to April 23, 2026 (i.e., 40 business days from the commencement of the Offer), a stockholder will also have the right to withdraw their tender of Shares after such date.

Please note that just as each stockholder has the right to withdraw its tender, subject to the applicable rules of the SEC, the Fund has the right to cancel, amend or postpone this Offer at any time before the Expiration Date.

------

The information required to be disclosed by paragraph (d)(1) of Rule 13e-4 under the Securities Exchange Act of 1934, as amended, is contained in the Offer to Purchase and is incorporated herein by reference. The information provided herein is qualified entirely by the more detailed information contained in the Offer to Purchase. The Offer to Purchase contains important information that should be read carefully before any decision is made with respect to the Offer. This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares. The Offer is made only by the Offer to Purchase and the related Notice of Intent. The Offer is not being made to, nor will tenders be accepted from or on behalf of, holders of Shares in any jurisdiction in which making or accepting the Offer would violate that jurisdiction's laws.

Questions and requests for assistance may be directed to the stockholder's financial advisor or to Bernstein at (212) 486-5800.

## Ex-99.(A)(5)(B)

**Exhibit (a)(5)(B)** 

---

| | |
|:---|:---|
|  ![LOGO](g111092dsp053.jpg)  | 66 Hudson Boulevard East<br> New York, NY 10001<br> www.Bernstein.com<br> +1 (212) 969 1000 |

---

[•]

[Stockholder Name]

---

| | |
|:---|:---|
| **Re:** | **AB Private Credit Investors Corporation**  |

---

**Tender Acceptance Notice** 

Dear Stockholder:

AB Private Credit Investors Corporation (the "Fund") acknowledges your request to tender to the Fund shares of the Fund's common stock, par value $0.01 per share (the "Shares"), on the terms and conditions set out in the Fund's Offer to Purchase (the "Offer to Purchase"). The Accepted Tender Amount (*i.e.*, the proceeds you will receive in respect of the tendered Shares) will be calculated based on (i) the number of Accepted Tender Shares shown below, (ii) the total number of Shares available for tender and (iii) the per share net asset value of the Fund ("NAV") as of the Tender Valuation Date.

---

| | |
|:---|:---|
|  Investment Account No. | XXX-XX[●] |
|  **Accepted Tender Shares** | **[**●**]** |
|  Offer to Purchase Dated | February 27, 2026 |
|  Tender Valuation Date | March 31, 2026 |

---

The Fund will confirm the Accepted Tender Amount to you in a subsequent letter once the NAV has been finalized. Proceeds in respect of the tendered Shares will be paid approximately forty-five days following the Tender Valuation Date.

Please refer to the Offer to Purchase for additional important information. If you have any questions regarding this notice, please contact your AB Advisor.

Sincerely,

AB Private Credit Investors LLC

The Adviser

## Ex-99.(A)(5)(C)

**Exhibit (a)(5)(C)** 

---

| | |
|:---|:---|
|  ![LOGO](g111092dsp053.jpg)  | 66 Hudson Boulevard East<br> New York, NY 10001<br> www.Bernstein.com<br> +1 (212) 969 1000 |

---

[•]

[Stockholder Name]

---

| | |
|:---|:---|
| **Re:** | **AB Private Credit Investors Corporation**  |

---

**Tender Confirmation** 

Dear Stockholder:

AB Private Credit Investors Corporation (the "Fund") confirms below the final details of your tender of shares of the Fund's common stock, par value $0.01 per share (the "Shares"), on the terms and conditions set out in the Fund's Offer to Purchase (the "Offer to Purchase").

---

| | |
|:---|:---|
|  Investment Account No. | XXX-XX[●] |
|  Offer to Purchase Dated | **February 27, 2026** |
|  Tender Valuation Date | **March 31, 2026** |
|  Accepted Tender Shares | [●] |
|  NAV as of Tender Valuation Date | $[●] |
|  **Accepted Tender Amount** | $[●] |

---

Approximately forty-five days following the Tender Valuation Date, the Accepted Tender Amount will be paid, and a trade confirmation issued.

Please refer to the Offer to Purchase for additional important information. If you have any questions regarding this confirmation, please contact your AB Advisor.

Sincerely,

AB Private Credit Investors LLC

The Adviser

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

 **Calculation of Filing Fee Tables** <br>

---

| | | | | |
|:---|:---|:---|:---|:---|
| | | **Transaction Valuation**  | **Fee Rate**  | **Amount of Filing Fee**  |
| Fees to be Paid | 1 | $17645126.65 | 0.0001381 | $2436.79 |
| Fees Previously Paid |  |  |  |  |
|  | Total Transaction Valuation: | $17645126.65  |  |  |
|  | Total Fees Due for Filing: |  |  | $2436.79  |
|  | Total Fees Previously Paid:  |  |  | $0.00  |
|  | Total Fee Offsets:  |  |  | $1946.31  |
|  | Net Fee Due:  |  |  | $490.48  |

---

 **Offering Note** <br>

<sup>1</sup> (1) Calculated solely for purposes of determining the amount of the filing fee. This amount is based upon the offer to purchase up to 1,861,300.28 shares of common stock, par value $0.01 per share, of AB Private Credit Investors Corporation, at a price equal to $9.48 per share, which represents the Fund's net asset value per share as of December 31, 2025, and is used for purposes of calculating the estimated aggregate maximum purchase price for shares. (2) The amount of the filing fee, calculated in accordance with Rule 0-11 under the Securities Exchange Act of 1934, as amended, as modified by that Section 6(b) Filing Fee Rate Advisory for Fiscal Year 2026, equals $138.10 per million dollars of the value of the transaction.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | Registrant or Filer Name | Form or Filing Type | File Number | Initial Filing Date | Filing Date | Fee Offset Claimed | Fee Paid with Fee Offset Source |
| Fee Offset Claims | 1, 2 |  | Schedule TO | 005-90731 | 11/28/2018 |  | $1534.52 |  |
| Fee Offset Claims | 3 |  | Schedule TO | 005-90731 | 02/22/2019 |  | $411.79 |  |
| Fee Offset Sources |  | AB Private Credit Investors Corp | Schedule TO | 005-90731 |  | 11/28/2018 |  | $1534.52 |
| Fee Offset Sources |  | AB Private Credit Investors Corp | Schedule TO | 005-90731 |  | 02/22/2019 |  | $411.79 |

---

 **Explanation of the basis for claimed offset:** <br>

<sup>1</sup> An aggregate fee of $1,552.81 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 22, 2019 (the "February 2019 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the February 2019 Schedule TO-I filed on March 27, 2019 was $8.81, as $72,667.54 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,552.81 filing fee paid in connection with the February 2019 Schedule TO-I is being used to offset a portion of the filing fee of the Schedule TO-I by the Company (File No. 005-90731) on November 28, 2025 (the "November 2025 Schedule TO-I"). More specifically, $1,102.21 from the filing fee paid in connection with the February 2019 Schedule TO-I was used to offset the final transaction fee due from the filing of the November 2025 Schedule TO-I. The remaining $411.79 portion of the filing fee paid in connection with the February 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.

<sup>3</sup> An aggregate fee of $1,542.78 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on November 28, 2018 (the "November 2018 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the November 2018 Schedule TO-I filed on December 28, 2018 was $8.26, as $68,121.91 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, the remaining portion of the $1,534.52 filing fee paid in connection with the February 2019 Schedule TO-I is being used to offset a portion of the filing fee in connection with this Schedule TO-I.

 **Offset Note** <br>

<sup>2</sup> (3) An aggregate fee of $941.37 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on August 26, 2022 (the "August 2022 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the August 2022 Schedule TO-I filed on November 14, 2022 was $329.58, as $3,555,388.97 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $941.37 filing fee paid in connection with the August 2022 Schedule TO-I was used to offset the filing fee due in connection with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 28, 2025 (the "February 2025 Schedule TO-I") and the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 23, 2025 (the "May 2025 Schedule TO-I"). More specifically, $589.61 from the filing fee paid in connection with the August 2022 Schedule TO-I was used to offset the final transaction fee due from the filing of the February 2025 Schedule TO-I, and $32.18 was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $819.09 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 27, 2022 (the "May 2022 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the May 2022 Schedule TO-I filed on August 12, 2022 was $555.34, as $5,990,764.58 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $819.09 filing fee paid in connection with the May 2022 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $263.75 from the filing fee paid in connection with the May 2022 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $721.64 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 25, 2022 (the "February 2022 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the February 2022 Schedule TO-I filed on May 13, 2022 was $378.34, as $4,081,369.77 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $721.64 filing fee paid in connection with the February 2022 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $343.30 from the filing fee paid in connection with the February 2022 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $635.45 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on November 26, 2021 (the "November 2021 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the November 2021 Schedule TO-I filed on February 16, 2022 was $439.04, as $4,736,138.63 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $635.45 filing fee paid in connection with the November 2021 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $196.41 from the filing fee paid in connection with the November 2021 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $1,359.69 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 28, 2021 (the "May 2021 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the May 2021 Schedule TO-I filed on August 5, 2021 was $1,224.15, as $11,220,395.48 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,359.69 filing fee paid in connection with the May 2021 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $135.54 from the filing fee paid in connection with the May 2021 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I. An aggregate fee of $2,125.52 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 26, 2021 (the "February 2021 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the February 2021 Schedule TO-I filed on May 10, 2021 was $1,206.85, as $11,061,880.89 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $2,125.52 filing fee paid in connection with the February 2021 Schedule TO-I was used to offset the filing fee due in connection with the filing of the May 2025 Schedule TO-I. More specifically, $270.26 from the filing fee paid in connection with the February 2021 Schedule TO-I was used to offset the final transaction fee due from the filing of the May 2025 Schedule TO-I, and $648.41 was used to offset the final transaction fee due from the filing of the August 2025 Schedule TO-I. An aggregate fee of $1,528.95 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on August 16, 2019 (the "August 2019 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the August 2019 Schedule TO-I filed on September 30, 2019 was $10.23, as $84,413.35 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,528.95 filing fee paid in connection with the August 2019 Schedule TO-I was used to offset the filing fee due in connection with the filing of the August 2025 Schedule TO-I. More specifically, $1,518.72 from the filing fee paid in connection with the August 2019 Schedule TO-I was used to offset the final transaction fee due from the filing of the August 2025 Schedule TO-I. An aggregate fee of $1,532.03 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on May 17, 2019 (the "May 2019 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the May 2019 Schedule TO-I filed on June 26, 2019 was $9.10, as $75,042.34 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,532.03 filing fee paid in connection with the May 2019 Schedule TO-I was used to offset the filing fee due in connection with the filing of the August 2025 Schedule TO-I and the November 2025 Schedule TO-I. More specifically, $322.02 from the filing fee paid in connection with the May 2019 Schedule TO-I was used to offset the final transaction fee due from the filing of the August 2025 Schedule TO-I and $1,200.91 was used to offset the final transaction fee due from the filing of the November 2025 Schedule TO-I. An aggregate fee of $1,552.81 was paid with the filing of the Schedule TO-I by the Company (File No. 005-90731) on February 22, 2019 (the "February 2019 Schedule TO-I"). The final transaction fee due pursuant to the final amendment to the February 2019 Schedule TO-I filed on March 27, 2019 was $8.81, as $72,667.54 of Shares were tendered in connection with the related tender offer. Pursuant to Rule 0-11(a)(2) under the Exchange Act, a portion of the remaining $1,552.81 filing fee paid in connection with the February 2019 Schedule TO-I was used to offset the filing fee due in connection with the filing of the November 2025 Schedule TO-I and is being used to offset a portion of the filing fee in connection with this Schedule TO-I. More specifically, $1,102.21 from the filing fee paid in connection with the February 2019 Schedule TO-I was used to offset the final transaction fee due from the filing of the November 2025 Schedule TO-I and $411.79 is being used to offset the final transaction fee due from the filing of this Schedule TO-I.